<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jats2jats3.xsl?><?ConverterInfo.Version 1?><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="iso-abbrev">J Ind Microbiol Biotechnol</journal-id><journal-id journal-id-type="publisher-id">jimb</journal-id><journal-title-group><journal-title>Journal of Industrial Microbiology &#x00026; Biotechnology</journal-title></journal-title-group><issn pub-type="ppub">1367-5435</issn><issn pub-type="epub">1476-5535</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmcid">10949845</article-id><article-id pub-id-type="pmid">38439699</article-id>
<article-id pub-id-type="doi">10.1093/jimb/kuae009</article-id><article-id pub-id-type="publisher-id">kuae009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject><subj-group subj-group-type="category-toc-heading"><subject>Natural Products</subject></subj-group></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>Jimb/10</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/SCI01150</subject><subject>AcademicSubjects/SCI00540</subject></subj-group></article-categories><title-group><article-title>CRISPR-aided genome engineering for secondary metabolite biosynthesis in <italic toggle="yes">Streptomyces</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Yongjae</given-names></name><aff>
<institution>Department of Biological Sciences, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Hwang</surname><given-names>Soonkyu</given-names></name><aff>
<institution>Department of Biological Sciences, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Woori</given-names></name><aff>
<institution>Department of Biological Sciences, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Ji Hun</given-names></name><aff>
<institution>Department of Biological Sciences, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Palsson</surname><given-names>Bernhard O</given-names></name><aff>
<institution>Department of Bioengineering, University of California San Diego</institution>, <addr-line>La Jolla, CA 92093</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Department of Pediatrics, University of California San Diego</institution>, <addr-line>La Jolla, CA 92093</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark</institution>, <addr-line>Lyngby 2800</addr-line>, <country country="DK">Denmark</country></aff></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4788-4184</contrib-id><name><surname>Cho</surname><given-names>Byung-Kwan</given-names></name><!--bcho@kaist.ac.kr--><aff>
<institution>Department of Biological Sciences, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff><aff>
<institution>KAIST Institute for the BioCentury, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff><aff>
<institution>Graduate school of Engineering Biology, Korea Advanced Institute of Science and Technology</institution>, <addr-line>Daejeon 34141</addr-line>, <country country="KP">Republic of Korea</country></aff><xref rid="cor1" ref-type="corresp"/></contrib></contrib-group><author-notes><corresp id="cor1">Correspondence should be addressed to: <email>bcho@kaist.ac.kr</email></corresp></author-notes><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-03-04"><day>04</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>04</day><month>3</month><year>2024</year></pub-date><volume>51</volume><elocation-id>kuae009</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2024</year></date><date date-type="accepted"><day>02</day><month>3</month><year>2024</year></date><date date-type="corrected-typeset"><day>19</day><month>3</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024. Published by Oxford University Press on behalf of Society of Industrial Microbiology and Biotechnology.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="kuae009.pdf"/><abstract><title>Abstract</title><sec id="abs1"><title>&#x000a0;</title><p>The demand for discovering novel microbial secondary metabolites is growing to address the limitations in bioactivities such as antibacterial, antifungal, anticancer, anthelmintic, and immunosuppressive functions. Among microbes, the genus <italic toggle="yes">Streptomyces</italic> holds particular significance for secondary metabolite discovery. Each <italic toggle="yes">Streptomyces</italic> species typically encodes approximately 30 secondary metabolite biosynthetic gene clusters (smBGCs) within its genome, which are mostly uncharacterized in terms of their products and bioactivities. The development of next-generation sequencing has enabled the identification of a large number of potent smBGCs for novel secondary metabolites that are imbalanced in number compared with discovered secondary metabolites. The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas) system has revolutionized the translation of enormous genomic potential into the discovery of secondary metabolites as the most efficient genetic engineering tool for <italic toggle="yes">Streptomyces</italic>. In this review, the current status of CRISPR/Cas applications in <italic toggle="yes">Streptomyces</italic> is summarized, with particular focus on the identification of secondary metabolite biosynthesis gene clusters and their potential applications.</p><p>This review summarizes the broad range of CRISPR/Cas applications in <italic toggle="yes">Streptomyces</italic> for natural product discovery and production.</p></sec><sec id="abs2"><title>One-Sentence Summary</title><p>This review summarizes the broad range of CRISPR/Cas applications in <italic toggle="yes">Streptomyces</italic> for natural product discovery and production.</p></sec></abstract><kwd-group kwd-group-type="keywords"><kwd><italic toggle="yes">Streptomyces</italic></kwd><kwd>CRISPR/Cas</kwd><kwd>biosynthetic gene cluster</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Bio &#x00026; Medical Technology Development Program</institution></institution-wrap>
</funding-source><award-id>2021M3A9I5023245</award-id></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>National Research Foundation</institution><institution-id institution-id-type="DOI">10.13039/501100001321</institution-id></institution-wrap>
</funding-source></award-group><award-group award-type="grant"><funding-source>
<institution-wrap><institution>Novo Nordisk Fonden</institution><institution-id institution-id-type="DOI">10.13039/501100009708</institution-id></institution-wrap>
</funding-source><award-id>NNF10CC1016517</award-id></award-group></funding-group><counts><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="sec2"><title>Introduction</title><p>Most of the currently used antibiotics were discovered during the &#x0201c;golden era of antibiotic discovery&#x0201d; spanning from the 1940s and 1960s (Lewis, <xref rid="bib47" ref-type="bibr">2013</xref>). Although novel types of antibiotics have rarely been discovered since that period, the demand for novel antibiotics has increased to address the escalating threat posed by multi-drug-resistant pathogens (Boucher et&#x000a0;al., <xref rid="bib8" ref-type="bibr">2009</xref>). The genus <italic toggle="yes">Streptomyces</italic>, consisting of a large number of species, holds significance as a major antibiotic producer. Approximately two-thirds of the clinically used antibiotics have been discovered in this genus. In addition, their secondary metabolites often possess additional beneficial activities related to medical, agricultural, and chemical applications, such as antitumorals and anthelmintics (Arcamone et&#x000a0;al., <xref rid="bib3" ref-type="bibr">1969</xref>; Burg et&#x000a0;al., <xref rid="bib10" ref-type="bibr">1979</xref>).</p><p>As an abundant reservoir of secondary metabolites, a single <italic toggle="yes">Streptomyces</italic> species is expected to encode approximately 30 secondary metabolite biosynthetic gene clusters (smBGCs) in its genome. However, the characterization of the products synthesized from many of the smBGCs has been limited (Lee et&#x000a0;al., <xref rid="bib43" ref-type="bibr">2020a</xref>). Considering the abundance of species within the <italic toggle="yes">Streptomyces</italic> genus and the ease of isolating novel species, the discovery of at least tens of thousands of novel smBGCs is anticipated, providing a potential breakthrough in meeting the growing demand for novel antibiotics that are effective against multidrug-resistant pathogens (Khattab et&#x000a0;al., <xref rid="bib37" ref-type="bibr">2016</xref>; Lee et&#x000a0;al., <xref rid="bib44" ref-type="bibr">2020b</xref>). Although genome mining of streptomycetes reveals the existence of numerous unexplored bioactive compounds in the genomes, the actual discovery of novel secondary metabolites is far behind their potential, as their secondary metabolism undergoes complex regulation, and smBGCs often remain silent under laboratory culture conditions (Craney et&#x000a0;al., <xref rid="bib14" ref-type="bibr">2013</xref>; Lee et&#x000a0;al., <xref rid="bib45" ref-type="bibr">2020c</xref>). Therefore, there is an urgent need to activate silent smBGCs to fully harness the genomic potential of <italic toggle="yes">Streptomyces</italic>.</p><p>Multiple approaches have been used to activate silent smBGCs in <italic toggle="yes">Streptomyces</italic>. One such approach involves indirectly activating smBGCs by mimicking the environmental signals required for activation. For example, the one strain&#x02013;many compound approach diversifies cultivation parameters, including media composition, aeration, temperature, and enzyme inhibitors, for a single strain to elicit secondary metabolism (Bode et&#x000a0;al., <xref rid="bib7" ref-type="bibr">2002</xref>). Cocultivation with other organisms can also activate secondary metabolism (Marmann et&#x000a0;al., <xref rid="bib63" ref-type="bibr">2014</xref>). However, these indirect approaches may result in the repetitive activation of the same smBGC in each trial. In addition, further efforts are required to identify the smBGCs encoded in the genome responsible for the biosynthesis of newly produced secondary metabolites.</p><p>Targeted activation of uncharacterized smBGCs is the preferred approach for the discovery of novel secondary metabolites, which involves engineering cluster-situated regulators, refactoring the target smBGC, and/or heterologous expression of the target smBGC (Baral et&#x000a0;al., <xref rid="bib5" ref-type="bibr">2018</xref>). Efficient genetic manipulation tools are required for targeted smBGC activation. Fortunately, efficient clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated (Cas)-mediated genome editing tools are available for <italic toggle="yes">Streptomyces</italic>, which have promoted the discovery of secondary metabolites (Tong et&#x000a0;al., <xref rid="bib79" ref-type="bibr">2020</xref>). In this review, the current applications of the CRISPR/Cas system in <italic toggle="yes">Streptomyces</italic> are briefly described and discuss the potential of the CRISPR/Cas system to boost natural product discovery.</p></sec><sec id="sec3"><title>CRISPR/Cas Systems Established in <italic toggle="yes">Streptomyces</italic></title><sec id="sec3-1"><title>CRISPR/Cas System for <italic toggle="yes">Streptomyces</italic> Genome Engineering</title><p>The CRISPR/Cas system usually consists of two components: a Cas protein with endonuclease activity and a guide RNA containing a spacer sequence that directs the endonuclease to its complementary protospacer sequence; a scaffold facilitates this interaction (Jinek et&#x000a0;al., <xref rid="bib35" ref-type="bibr">2012</xref>). The Cas endonuclease induces double-stranded DNA breaks (DSB) through two nuclease domains, HNH (complementary strand) and RuvC-like (non-complementary strand), only when the correct protospacer adjacent motif (PAM) is present, which precisely targets the CRISPR/Cas complex to the protospacer. Genome engineering using CRISPR/Cas involves the repair of DSB via either non-homologous end-joining (NHEJ) or homology-directed repair (HDR). During DNA repair via the NHEJ pathway, small insertions or deletions occur randomly at the DNA cleavage site (Doudna &#x00026; Charpentier, <xref rid="bib16" ref-type="bibr">2014</xref>). In contrast, precise genome editing is enabled through DNA repair via the HDR pathway, which requires the donor DNA to be recombined into the cleavage site. Genes involved in the bacterial NHEJ pathway are absent in most <italic toggle="yes">Streptomyces</italic> species, and thus, genome editing mediated by the HDR pathway is preferred for CRISPR/Cas-based genetic engineering (Tong et&#x000a0;al., <xref rid="bib78" ref-type="bibr">2015</xref>). Conventionally, achieving precise and scarless genome editing in <italic toggle="yes">Streptomyces</italic> was mostly dependent on double-crossover events, which required time-consuming and labor-intensive screening steps (Kieser et&#x000a0;al., <xref rid="bib38" ref-type="bibr">2000</xref>). Given the lethal DSB induced by the CRISPR/Cas system in bacteria unless repaired, the surviving cells after transformation of the CRISPR/Cas plasmid are more likely to be successfully engineered. Consequently, the time and labor required for the screening steps are dramatically reduced (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1A</xref>) (Cobb et&#x000a0;al., <xref rid="bib13" ref-type="bibr">2015</xref>; Tong et&#x000a0;al., <xref rid="bib78" ref-type="bibr">2015</xref>).</p><fig position="float" id="fig1"><label>Fig. 1.</label><caption><p>Genome engineering of <italic toggle="yes">Streptomyces</italic> using CRISPR/Cas system. (A) Comparison of gene deletion processes between CRISPR/Cas-mediated engineering and conventional double crossover-mediated engineering. (B) Types of CRISPR/Cas system exploited in <italic toggle="yes">Streptomyces</italic>.</p></caption><graphic xlink:href="kuae009fig1" position="float"/></fig><p>The first CRISPR/Cas system applied to <italic toggle="yes">Streptomyces</italic> was based on the class 2&#x02013;type II CRISPR system, which uses Cas9 from <italic toggle="yes">Streptococcus pyogenes</italic> as a nuclease (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1B</xref>) (Cobb et&#x000a0;al., <xref rid="bib13" ref-type="bibr">2015</xref>). Cas9 requires 5&#x02032;-NGG-3&#x02032; as the PAM, which is frequently found in the GC-rich <italic toggle="yes">Streptomyces</italic> genomes. Using the CRISPR/Cas9 system, genomic deletions of up to 31.4&#x000a0;kbp have been performed in three <italic toggle="yes">Streptomyces</italic> species: <italic toggle="yes">S. lividans, S. viridochromogenes</italic>, and <italic toggle="yes">S. albus</italic> (Cobb et&#x000a0;al., <xref rid="bib13" ref-type="bibr">2015</xref>). Around the same period, additional CRISPR/Cas9 systems were explored, leading to additional applications and advancements (Huang et&#x000a0;al., <xref rid="bib28" ref-type="bibr">2015</xref>; Tong et&#x000a0;al., <xref rid="bib78" ref-type="bibr">2015</xref>; Zeng et&#x000a0;al., <xref rid="bib94" ref-type="bibr">2015</xref>). To enhance genome editing efficiency via the NHEJ pathway, DNA ligase D, a core component of the NHEJ pathway, was co-expressed with the CRISPR/Cas system (Tong et&#x000a0;al., <xref rid="bib78" ref-type="bibr">2015</xref>). Although the mutations induced by NHEJ-mediated DNA repair are random, the enhanced editing efficiency can facilitate rapid gene disruption as there is no requirement for donor DNAs for homologous recombination. In addition, although most CRISPR/Cas9 systems rely on a temperature-sensitive origin to cure the plasmid, an alternative counterselection method for screening plasmid-cured strains has been described (Zeng et&#x000a0;al., <xref rid="bib94" ref-type="bibr">2015</xref>). A mutant cytosine deaminase, which converts 5-fluorocytosine into the highly toxic 5-fluorouracil, was integrated into the CRISPR/Cas9 plasmid, and treatment with 5-fluorocytosine effectively eliminates the strains retaining the plasmid (Zeng et&#x000a0;al., <xref rid="bib94" ref-type="bibr">2015</xref>).</p><p>The CRISPR/Cas system for <italic toggle="yes">Streptomyces</italic> is gradually evolving by expanding its applicable hosts, including <italic toggle="yes">S. rimosus, S. ambofaciens</italic>, and <italic toggle="yes">S. roseosporus</italic>, and exploiting different types of CRISPR/Cas systems (Jia et&#x000a0;al., <xref rid="bib32" ref-type="bibr">2017</xref>; Li et&#x000a0;al., <xref rid="bib49" ref-type="bibr">2018</xref>; Najah et&#x000a0;al., <xref rid="bib71" ref-type="bibr">2019</xref>; Yeo et&#x000a0;al., <xref rid="bib91" ref-type="bibr">2019</xref>; Jiang et&#x000a0;al., <xref rid="bib34" ref-type="bibr">2021</xref>). Especially, the class 2&#x02013;type V CRISPR/Cas system, exploiting Cas12a from <italic toggle="yes">Francisella novicida</italic>, was applied to <italic toggle="yes">Streptomyces</italic>, expanding the number of editable DNA sequences with 5&#x02032;-TTV-3&#x02032; (V&#x000a0;=&#x000a0;A, G, or C) PAM (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1B</xref>) (Li et&#x000a0;al., <xref rid="bib49" ref-type="bibr">2018</xref>). Although the 5&#x02032;-NGG-3&#x02032; PAM of Cas9 may provide a wide range of potential editing targets, the AT-rich PAM of Cas12a provides advantages for target specificity in the GC-rich genome of <italic toggle="yes">Streptomyces</italic>. In addition, Cas12a is more suited for multiplexing compared to Cas9, because it enables the maturation of CRISPR RNA (crRNA) (Zetsche et&#x000a0;al., <xref rid="bib95" ref-type="bibr">2017</xref>).</p><p>In addition to expanding the PAM sequence, the establishment of different types of CRISPR/Cas systems for engineering <italic toggle="yes">Streptomyces</italic> is important because the exploration of secondary metabolites spans the entire genus, and the applicability of a specific type of CRISPR system may differ from species to species (Li et&#x000a0;al., <xref rid="bib49" ref-type="bibr">2018</xref>; Yeo et&#x000a0;al., <xref rid="bib91" ref-type="bibr">2019</xref>). Both CRISPR/Cas9 and CRISPR/Cas12a are convenient to use because only a single Cas protein is required to induce DSB in the genome (Pickar-Oliver &#x00026; Gersbach, <xref rid="bib72" ref-type="bibr">2019</xref>). However, the introduced foreign CRISPR/Cas system may crosstalk with the native CRISPR/Cas system encoded within the <italic toggle="yes">Streptomyces</italic> genome, resulting in reduced engineering efficiency and severe defects in the host (Qiu et&#x000a0;al., <xref rid="bib74" ref-type="bibr">2016</xref>). In particular, the class 1 type I CRISPR/Cas system, which requires a Cas3 nuclease and a ribonucleoprotein complex comprising Cas5, Cas7, Cas8 proteins, and crRNA, is the most widespread CRISPR/Cas system in <italic toggle="yes">Streptomyces</italic>. Thus, class 1 type I CRISPR/Cas could be advantageous for a broad range of <italic toggle="yes">Streptomyces</italic> species (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1B</xref>) (Whitford et&#x000a0;al., <xref rid="bib87" ref-type="bibr">2023a</xref>).</p></sec><sec id="sec3-2"><title>Utilization of Mutated Cas Proteins for <italic toggle="yes">Streptomyces</italic> Genome Engineering</title><p>Although the CRISPR/Cas system is efficient (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1A</xref>), there are some shortcomings associated with its application in the genome engineering of <italic toggle="yes">Streptomyces</italic>. In addition to inherent cytotoxicity, genome engineering using the CRISPR/Cas system is accompanied by DSB, which may induce severe instability in the linear genome of <italic toggle="yes">Streptomyces</italic> (Hoff et&#x000a0;al., <xref rid="bib26" ref-type="bibr">2018</xref>). To reduce the lethality occurring from DSB, Cas9 variant nicking DNA (nCas), rather than cleaving double-stranded DNA, can be used to edit the genome (Ma et&#x000a0;al., <xref rid="bib60" ref-type="bibr">2023</xref>). Genetic engineering using nCas variants is particularly effective for strains with low transformation efficiency. For example, the exploitation of nCas9 resulted in the recovery of hundreds more colonies from the transformation of an industrial <italic toggle="yes">Streptomyces</italic> strain, compared to the below 10 colonies when conventional Cas9 system was applied (Ma et&#x000a0;al., <xref rid="bib60" ref-type="bibr">2023</xref>).</p><p>An additional drawback of the CRISPR/Cas system may not be suitable for inducing point mutations as the guide RNA can still bind to the edited genome with a single mismatch (Zheng et&#x000a0;al., <xref rid="bib100" ref-type="bibr">2017</xref>). To overcome this potential limitation, cytidine or adenosine deaminase is fused with nCas9 to form the base editor with high specificity for the target sequence driven by the CRISPR/Cas system (Fig.&#x000a0;<xref rid="fig2" ref-type="fig">2A</xref>) (Tong et&#x000a0;al., <xref rid="bib80" ref-type="bibr">2019</xref>). Deaminated cytidine or adenine are eventually substituted with thymidine or guanosine, respectively, through a nucleotide excision repair process. Base editors can disrupt a start codon or introduce a stop codon to effectively generate a knockout mutant (Tong et&#x000a0;al., <xref rid="bib80" ref-type="bibr">2019</xref>; Wang et&#x000a0;al., <xref rid="bib84" ref-type="bibr">2020a</xref>). For example, a point mutation generated by a base editor facilitates the understanding of translational regulation in <italic toggle="yes">Streptomyces</italic>, such as the important regulatory role of the rare leucine codon UUA, decoded by a specific tRNA, <italic toggle="yes">bldA</italic>, in the development and secondary metabolism (Chater &#x00026; Chandra, <xref rid="bib11" ref-type="bibr">2008</xref>).</p><fig position="float" id="fig2"><label>Fig. 2.</label><caption><p>Utilization of mutated Cas proteins for genetic engineering of <italic toggle="yes">Streptomyces</italic>. (A) CRISPR base editors exploiting nCas9 and deaminase. (B) Transcriptional repression and activation exploiting dCas9.</p></caption><graphic xlink:href="kuae009fig2" position="float"/></fig><p>The RNA-guided DNA binding ability of the CRISPR/Cas system has a broad range of applications. In addition to editing the genome sequence, the CRISPR/Cas system can be used to modulate gene expression via CRISPR interference (CRISPRi) and activation (CRISPRa) in <italic toggle="yes">Streptomyces</italic> (Fig.&#x000a0;<xref rid="fig2" ref-type="fig">2B</xref>) (Tong et&#x000a0;al., <xref rid="bib78" ref-type="bibr">2015</xref>; Li et&#x000a0;al., <xref rid="bib49" ref-type="bibr">2018</xref>; Ameruoso et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2022</xref>). Nuclease-dead Cas (dCas) variants can prevent the binding of transcriptional machinery to DNA or serve as roadblocks for transcribing RNA polymerase (Larson et&#x000a0;al., <xref rid="bib41" ref-type="bibr">2013</xref>). In addition, dCas can be fused with a transcriptional activator such as the N-terminal domain of the RNA polymerase &#x003b1; subunit, to promote transcription in the vicinity of the guide RNA targeted region (Maeder et&#x000a0;al., <xref rid="bib61" ref-type="bibr">2013</xref>; Ameruoso et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2022</xref>).</p></sec></sec><sec id="sec4"><title>CRISPR/Cas Applications for Natural Product Research in <italic toggle="yes">Streptomyces</italic></title><sec id="sec4-1"><title>Characterization of Smbgcs Using the CRISPR/Cas System</title><p>Owing to their unparalleled convenience, CRISPR/Cas-based engineering tools are rapidly replacing conventional tools, finding broad applications in diverse aspects of natural product research, from the characterization of smBGCs to the enhancement of secondary metabolite production. For example, formicamycins, which show antimicrobial activity against methicillin-resistant <italic toggle="yes">Staphylococcus aureus</italic> and vancomycin-resistant enterococci, have been discovered in the <italic toggle="yes">Streptomyces</italic> isolate <italic toggle="yes">S. formicae</italic> KY5 (Qin et&#x000a0;al., <xref rid="bib73" ref-type="bibr">2017</xref>). To identify the responsible smBGC, the entire region of the type 2 polyketide synthase (PKS) BGC was deleted using CRISPR/Cas9, resulting in the inactivation of formicamycin production. This strategy has been applied to identify smBGCs for multiple secondary metabolites, including sceliphrolactam, valinomycin, and griseusin, by deleting a synthesis gene in the smBGC or introducing a stop codon in the synthesis gene using the CRISPR/Cas system or base editor, respectively (Low et&#x000a0;al., <xref rid="bib58" ref-type="bibr">2018</xref>; Jeon et&#x000a0;al., <xref rid="bib30" ref-type="bibr">2019</xref>; Beck et&#x000a0;al., <xref rid="bib6" ref-type="bibr">2021</xref>). Furthermore, the ease of smBGC disruption enables functional screening of smBGCs. In <italic toggle="yes">S. globisporus</italic> SP6C4, the biosynthetic genes of 15 smBGCs were deleted using the CRISPR/Cas system, and the smBGC-disrupted strains were tested for antifungal and antibacterial activities, revealing three bioactive lantipeptide- or lassopeptide-type secondary metabolites (Kim &#x00026; Kwak, <xref rid="bib39" ref-type="bibr">2021</xref>).</p><p>The CRISPR/Cas system enabled not only the identification of the smBGC responsible for secondary metabolite production but has also played a key role in the elucidation of their biosynthetic pathway. For example, three genes in the anthelvencin BGC were deleted using the CRISPR/Cas9 system, and their role in anthelvencin synthesis was confirmed (Lee et&#x000a0;al., <xref rid="bib42" ref-type="bibr">2021</xref>). This approach has also been applied to other secondary metabolites, including neoantimycin and hygromycin B, to characterize the functions of genes during secondary metabolite biosynthesis (Skyrud et&#x000a0;al., <xref rid="bib76" ref-type="bibr">2018</xref>; Li et&#x000a0;al., <xref rid="bib51" ref-type="bibr">2020a</xref>). In addition to the genes directly involved in secondary metabolite synthesis, genes affecting secondary metabolism outside smBGCs have also been characterized using the CRISPR/Cas system (He et&#x000a0;al., <xref rid="bib24" ref-type="bibr">2016</xref>; Li et&#x000a0;al., <xref rid="bib52" ref-type="bibr">2020b</xref>; Lee et&#x000a0;al., <xref rid="bib46" ref-type="bibr">2020d</xref>; Hou et&#x000a0;al., <xref rid="bib27" ref-type="bibr">2021</xref>). For example, the redox-sensitive regulator Rex was deleted in <italic toggle="yes">S. lincolnensis</italic>, and the deletion mutant produced a lower amount of lincomycin, suggesting that Rex is involved in the regulation of lincomycin biosynthesis (Hou et&#x000a0;al., <xref rid="bib27" ref-type="bibr">2021</xref>). Similarly, the CRISPR/Cas system is innovative for characterizing smBGCs because of its high precision and speed, and is likely to accelerate the discovery of novel secondary metabolites using base editors.</p></sec><sec id="sec4-2"><title>Utilization of the CRISPR/Cas System for Secondary Metabolite Production</title><p>The ultimate goal of engineering <italic toggle="yes">Streptomyces</italic> is the production of large amounts of valuable natural products. Secondary metabolite production can be enhanced by controlling the expression of biosynthetic genes or modulating regulatory genes related to the biosynthetic pathway of the target molecule (Wang et&#x000a0;al., <xref rid="bib85" ref-type="bibr">2020b</xref>; Li et&#x000a0;al., <xref rid="bib48" ref-type="bibr">2022</xref>). To elevate the expression of the target smBGC, various strategies can be applied, including deletion of negative regulators, overexpression of positive regulators, refactoring of the promoters of biosynthetic genes, and multiplying the copy number of the smBGC (Table <xref rid="tbl1" ref-type="table">1</xref>).</p><table-wrap position="float" id="tbl1"><label>Table 1.</label><caption><p>
<italic toggle="yes">In vivo</italic> Applications of CRISPR/Cas System for Enhancement of Secondary Metabolite Production</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">`Strategy</th><th align="left" rowspan="1" colspan="1">Cas protein</th><th align="center" rowspan="1" colspan="1">Engineered species</th><th align="center" rowspan="1" colspan="1">Target secondary metabolite</th><th align="center" rowspan="1" colspan="1">Engineering</th><th align="center" rowspan="1" colspan="1">Year</th><th align="center" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Knock-in</td><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. pristinaespiralis</italic>
</td><td rowspan="1" colspan="1">Pristinamycin II</td><td rowspan="1" colspan="1">Knock-in of attB integration sites for smBGC copy number increasement</td><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">(Li et&#x000a0;al., <xref rid="bib50" ref-type="bibr">2017</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td rowspan="1" colspan="1">Chloramphenicol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td rowspan="1" colspan="1">YM-216&#x000a0;391</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td rowspan="1" colspan="1">Undecylprodigiosin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">(Liu et&#x000a0;al., <xref rid="bib56" ref-type="bibr">2017</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. albidoflavus</italic>
</td><td rowspan="1" colspan="1">Eriodictyol</td><td rowspan="1" colspan="1">Knock-in of genes for precursor supply</td><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">(Magad&#x000e1;n-Corpas et&#x000a0;al., <xref rid="bib62" ref-type="bibr">2023</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">Unknown type I PKS</td><td rowspan="1" colspan="1">Promoter knock-in of biosynthetic genes or a positive regulator</td><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">(Zhang et&#x000a0;al., <xref rid="bib98" ref-type="bibr">2017</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. albus</italic>
</td><td rowspan="1" colspan="1">Indigoidine</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td rowspan="1" colspan="1">Actinorhodin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. coelicolor</italic>
</td><td rowspan="1" colspan="1">Undecylprodigiosin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">Polycyclic tetramate macrolactam</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">FR-900&#x000a0;098</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. venezuelae</italic>
</td><td rowspan="1" colspan="1">Unknown type III PKS</td><td rowspan="1" colspan="1">Promoter knock-in of biosynthetic genes</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. viridochromogenes</italic>
</td><td rowspan="1" colspan="1">Unknown type II PKS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">Auroramycin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2018</td><td rowspan="1" colspan="1">(Lim et&#x000a0;al., <xref rid="bib54" ref-type="bibr">2018</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces</italic> sp. AL2110</td><td rowspan="1" colspan="1">Deacyl-antimycin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2019</td><td rowspan="1" colspan="1">(Mo et&#x000a0;al., <xref rid="bib68" ref-type="bibr">2019</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces</italic> sp. A793</td><td rowspan="1" colspan="1">Armeniaspirols</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">(Heng et&#x000a0;al., <xref rid="bib25" ref-type="bibr">2023</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas12a</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">Daptomycin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2020</td><td rowspan="1" colspan="1">(Zhang et&#x000a0;al., <xref rid="bib96" ref-type="bibr">2020</xref>)</td></tr><tr><td rowspan="1" colspan="1">Deletion</td><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. fradiae</italic>
</td><td rowspan="1" colspan="1">Neomycin</td><td rowspan="1" colspan="1">Deletion of a repressor</td><td rowspan="1" colspan="1">2019</td><td rowspan="1" colspan="1">(Zheng et&#x000a0;al., <xref rid="bib99" ref-type="bibr">2019</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. lincolnensis</italic>
</td><td rowspan="1" colspan="1">Lincomycin</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">(Wang et&#x000a0;al., <xref rid="bib83" ref-type="bibr">2023b</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. roseosporus</italic>
</td><td rowspan="1" colspan="1">Daptomycin</td><td rowspan="1" colspan="1">Deletion of genes of competitive pathway</td><td rowspan="1" colspan="1">2022</td><td rowspan="1" colspan="1">(Ji et&#x000a0;al., <xref rid="bib31" ref-type="bibr">2022</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. albidoflavus</italic>
</td><td rowspan="1" colspan="1">Eriodictyol</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">(Magad&#x000e1;n-Corpas et&#x000a0;al., <xref rid="bib62" ref-type="bibr">2023</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">Streptomyces</italic> sp. A793</td><td rowspan="1" colspan="1">Armeniaspirols</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">2023</td><td rowspan="1" colspan="1">(Heng et&#x000a0;al., <xref rid="bib25" ref-type="bibr">2023</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. pristinaespiralis</italic>
</td><td rowspan="1" colspan="1">Pristinamycin I</td><td rowspan="1" colspan="1">Deletion of genes of competitive pathway and a repressor</td><td rowspan="1" colspan="1">2017</td><td rowspan="1" colspan="1">(Meng et&#x000a0;al., <xref rid="bib65" ref-type="bibr">2017</xref>)</td></tr><tr><td rowspan="1" colspan="1">CRISPRi</td><td rowspan="1" colspan="1">dCas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. venezuelae</italic>
</td><td rowspan="1" colspan="1">Pikromycin</td><td rowspan="1" colspan="1">Repression of a gene negatively affecting secondary metabolite production</td><td rowspan="1" colspan="1">2022</td><td rowspan="1" colspan="1">(Cho et&#x000a0;al., <xref rid="bib12" ref-type="bibr">2022</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">dCas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. rapamycinicus</italic>
</td><td rowspan="1" colspan="1">Rapamycin</td><td rowspan="1" colspan="1">Repression of genes of competitive pathway</td><td rowspan="1" colspan="1">2020</td><td rowspan="1" colspan="1">(Tian et&#x000a0;al., <xref rid="bib77" ref-type="bibr">2020</xref>)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">dCas9</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. venezuelae</italic>
</td><td rowspan="1" colspan="1">Jadomycin B</td><td rowspan="1" colspan="1">Repression of negative regulator</td><td rowspan="1" colspan="1">2022</td><td rowspan="1" colspan="1">(Ameruoso et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2022</xref>)</td></tr><tr><td rowspan="1" colspan="1">CRISPRa</td><td rowspan="1" colspan="1">dCas9-&#x003b1;NTD</td><td rowspan="1" colspan="1">
<italic toggle="yes">S. venezuelae</italic>
</td><td rowspan="1" colspan="1">Jadomycin B</td><td rowspan="1" colspan="1">Activation of biosynthetic genes</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>In smBGCs, cluster-situated regulators often positively or negatively regulate the transcription of biosynthetic genes, which are attractive engineering targets. For example, <italic toggle="yes">neoI</italic>, a negative regulator of neomycin biosynthesis, was deleted to enhance neomycin production (Zheng et&#x000a0;al., <xref rid="bib99" ref-type="bibr">2019</xref>). Furthermore, CRISPRi can be used to repress inhibitors and eventually activate the transcription of biosynthetic genes (Ameruoso et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2022</xref>). The expression of <italic toggle="yes">jadR2</italic>, a repressor of the positive regulator of jadomycin biosynthesis, was reduced by CRISPRi, resulting in the induction of jadomycin production in <italic toggle="yes">S. venezuelae</italic>. In the case of positive regulators, the upstream region of <italic toggle="yes">aurR1</italic>, a positive regulator of auroramycin BGC, was engineered by employing the constitutive <italic toggle="yes">kasO*</italic> promoter to activate transcription of biosynthetic genes in <italic toggle="yes">S. roseosporus</italic> (Lim et&#x000a0;al., <xref rid="bib54" ref-type="bibr">2018</xref>). Modulation of regulatory genes represents an efficient strategy to transcriptionally activate smBGCs, as engineering only one target is required; however, secondary metabolism is subject to complex regulation, and multiple regulators may regulate smBGCs, limiting the effectiveness of the engineered regulator (Liu et&#x000a0;al., <xref rid="bib55" ref-type="bibr">2019a</xref>). Engineering the promoters of secondary metabolite biosynthetic genes enables not only transcriptional activation but also the construction of an orthogonal regulatory network for the targeted smBGC. The promoter replacement of biosynthesis genes using the CRISPR/Cas system has been used to enhance secondary metabolite production or activate transcriptionally silent smBGCs in multiple <italic toggle="yes">Streptomyces</italic> species (Zhang et&#x000a0;al., <xref rid="bib98" ref-type="bibr">2017</xref>; Mo et&#x000a0;al., <xref rid="bib68" ref-type="bibr">2019</xref>).</p><p>Increasing the copy number of smBGC can significantly enhance secondary metabolite production. To this end, phage site-specific recombination systems are commonly utilized rather than directly inserting the entire smBGC using the CRISPR/Cas system (Li et&#x000a0;al., <xref rid="bib50" ref-type="bibr">2017</xref>). The <italic toggle="yes">attB</italic> integration sites are first inserted into the genome of <italic toggle="yes">Streptomyces</italic> using the CRISPR/Cas system, and the plasmid bearing the target smBGCs, <italic toggle="yes">attP</italic> site, and site-specific integrase can be inserted into the <italic toggle="yes">attB</italic> sites in the genome. While the CRISPR/Cas-based direct smBGC insertion method requires the preparation of editing templates for HDR, the <italic toggle="yes">attB</italic> insertion method is advantageous in that an engineered strain with multiple <italic toggle="yes">attB</italic> sites can be readily utilized without additional labor. However, the major drawback of an increase in the smBGC copy number is that silent smBGCs remain inactive regardless of the number of smBGCs in the genome; therefore, a readily applicable smBGC activation strategy is required. The CRISPRa strategy is an excellent option for <italic toggle="yes">Streptomyces</italic>, similar to the promoter knock-in strategy (Table <xref rid="tbl1" ref-type="table">1</xref>). Although the expression of jadomycin B synthesis genes could be enhanced by exploiting CRISPRa in <italic toggle="yes">S. venezuelae</italic>, further optimization is required to effectively utilize CRISPRa in <italic toggle="yes">Streptomyces</italic>, as the efficiency of gene activation via CRISPRa in bacteria is heavily dependent on the targeting position and promoter type (Fontana et&#x000a0;al., <xref rid="bib20" ref-type="bibr">2020</xref>; Ameruoso et&#x000a0;al., <xref rid="bib1" ref-type="bibr">2022</xref>;). For this, dCas9 variants with expanded PAM sequences can be utilized (Fontana et&#x000a0;al., <xref rid="bib20" ref-type="bibr">2020</xref>). To date, a versatile transcriptional activator, such as VP64 in the eukaryotic CRISPRa system, is absent in bacterial CRISPRa; thus, screening other transcriptional activators is required for the efficient application of CRISPRa in bacteria (Gilbert et&#x000a0;al., <xref rid="bib21" ref-type="bibr">2014</xref>; Liu et&#x000a0;al., <xref rid="bib57" ref-type="bibr">2019b</xref>).</p><p>In addition to CRISPRa, other CRISPR/Cas-based genetic tools should be utilized to foster secondary metabolite research in <italic toggle="yes">Streptomyces</italic>. For instance, a new type of CRISPR/Cas-based genome editing tool called prime editing has been developed, which is advantageous for inserting short sequences (Anzalone et&#x000a0;al., <xref rid="bib2" ref-type="bibr">2019</xref>). Prime editing consists of nCas9 fused with a reverse transcriptase and an extended guide RNA containing the primer-binding site and editing template for reverse transcription. Compared to CRISPR/Cas-based genome editing with the HDR pathway, prime editing is less toxic because a nick, rather than a DSB, is introduced in the genome. Additionally, constructing the plasmid is simplified as cloning of the donor template is not required. Given that T7 RNA polymerase can be utilized in <italic toggle="yes">Streptomyces</italic> for orthogonal expression, the insertion of a short T7 promoter sequence using a prime editing system would enable the expression of smBGCs, bypassing the host's transcriptional regulatory network (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3A</xref>) (Lussier et&#x000a0;al., <xref rid="bib59" ref-type="bibr">2010</xref>; Wei et&#x000a0;al., <xref rid="bib86" ref-type="bibr">2017</xref>).</p><fig position="float" id="fig3"><label>Fig. 3.</label><caption><p>Potential application of CRISPR/Cas tools for secondary metabolite production. (A) Promoter replacement of secondary metabolite biosynthesis genes by exploiting prime editing. (B) Application of toehold-gated guide RNA for coordinating precursor supply and smBGC activation.</p></caption><graphic xlink:href="kuae009fig3" position="float"/></fig><p>For the timely control of gene expression, the CRISPR/Cas system regulated by inducible promoters could be effective for increasing secondary metabolite production. Recently, a cumate-inducible promoter was used to control the expression of both guide RNA and dCas9, and CRISPRi was found to be tightly regulated by the presence of cumates in various <italic toggle="yes">Streptomyces</italic> species (Bai &#x00026; van Wezel, <xref rid="bib4" ref-type="bibr">2023</xref>). In addition, the activity of the CRISPR/Cas system can be autonomously regulated by utilizing toehold-gated guide RNA (Siu &#x00026; Chen, <xref rid="bib75" ref-type="bibr">2019</xref>; Wang et&#x000a0;al., <xref rid="bib82" ref-type="bibr">2023a</xref>), which activates the inactive modified guide RNA through toehold-mediated strand displacement by interacting with the host transcripts. The CRISPRi and CRISPRa systems can effectively coordinate the precursor supply with the onset of secondary metabolism by utilizing the transcripts of precursor supply genes as trigger strands (Fig.&#x000a0;<xref rid="fig3" ref-type="fig">3B</xref>). The integration of controllable CRISPRi and CRISPRa systems with precursor supply holds potential for significant advancements in secondary metabolite production.</p></sec><sec id="sec4-3"><title>Exploiting CRISPR/Cas Systems for Heterologous Expression of Smbgcs</title><p>Although CRISPR/Cas systems have been successfully used in several <italic toggle="yes">Streptomyces</italic> species, the exploration of a large number of species is required for novel secondary metabolite discovery. Species-level heterogeneity often results in an inconsistent success rate or even the inability to achieve CRISPR/Cas-based genome editing for certain species (Cobb et&#x000a0;al., <xref rid="bib13" ref-type="bibr">2015</xref>; Li et&#x000a0;al., <xref rid="bib49" ref-type="bibr">2018</xref>; Yeo et&#x000a0;al., <xref rid="bib91" ref-type="bibr">2019</xref>). Furthermore, some species may display slow growth rates in laboratory culture conditions or in the absence of proper genetic manipulation tools, further limiting <italic toggle="yes">in vivo</italic> CRISPR/Cas applications (Kieser et&#x000a0;al., <xref rid="bib38" ref-type="bibr">2000</xref>). Additionally, many <italic toggle="yes">Streptomyces</italic> suffer from severe genetic instability, making it difficult to maintain engineered genotypes (Volff &#x00026; Altenbuchner, <xref rid="bib81" ref-type="bibr">1998</xref>). Therefore, heterologous expression of smBGCs in well-established <italic toggle="yes">Streptomyces</italic> hosts is advantageous over the manipulation of each <italic toggle="yes">Streptomyces</italic> isolate. The CRISPR/Cas system can be utilized in diverse steps of smBGC heterologous expression, including the construction of a heterologous expression host, cloning of smBGC, and refactoring of smBGC with host-recognizable regulatory sequences (Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref>) (Kang et&#x000a0;al., <xref rid="bib36" ref-type="bibr">2016</xref>; Fazal et&#x000a0;al., <xref rid="bib19" ref-type="bibr">2020</xref>; Wu et&#x000a0;al., <xref rid="bib89" ref-type="bibr">2020</xref>).</p><fig position="float" id="fig4"><label>Fig. 4.</label><caption><p>Heterologous expression of smBGCs harnessing the potential of the CRISPR/Cas system.</p></caption><graphic xlink:href="kuae009fig4" position="float"/></fig><p>The construction of a host strain for the heterologous expression of smBGCs often involves the deletion of the host's smBGCs. The deletion of smBGCs proves beneficial for heterologous expression because of the increased cellular resources required for secondary metabolite synthesis (Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref>). In particular, PKSs commonly utilize malonyl- or methylmalonyl-CoA as a substrate, and the deletion of competing PKS-type BGCs can enhance the production of other polyketide-type secondary metabolites (Meng et&#x000a0;al., <xref rid="bib66" ref-type="bibr">2016</xref>; Hwang et&#x000a0;al., <xref rid="bib29" ref-type="bibr">2020</xref>). Furthermore, the smBGC-free host strain may provide a metabolically clean background for the detection of secondary metabolites synthesized from the introduced smBGC (Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref>) (Myronovskyi et&#x000a0;al., <xref rid="bib70" ref-type="bibr">2018</xref>; Bu et&#x000a0;al., <xref rid="bib9" ref-type="bibr">2019</xref>). Although only two <italic toggle="yes">Streptomyces</italic> strains, <italic toggle="yes">S. albus</italic> and <italic toggle="yes">S. griseofuscus</italic>, have been constructed using the CRISPR/Cas system, more smBGC-free heterologous expression host strains will be constructed in the near future (Fazal et&#x000a0;al., <xref rid="bib19" ref-type="bibr">2020</xref>; Gren et&#x000a0;al., <xref rid="bib22" ref-type="bibr">2021</xref>). In particular, large genomic deletions can induce severe defects in bacteria; thus, carefully supervised genome reduction with high-precision and time-saving genome editing by the CRISPR/Cas system is mandatory (Fig.&#x000a0;<xref rid="fig1" ref-type="fig">1A</xref>) (Dervyn et&#x000a0;al., <xref rid="bib15" ref-type="bibr">2023</xref>). In addition, the utilization of CRISPR base editors to introduce premature stop codons to inactivate secondary metabolite synthesis genes enables extremely fast functional knockouts of smBGCs, harnessing the ease of multiplexity (Whitford et&#x000a0;al., <xref rid="bib88" ref-type="bibr">2023b</xref>). However, further optimization is required to increase the efficiency of premature stop codon generation.</p><p>After the construction of a highly efficient host strain for heterologous expression, the smBGC of interest was cloned. However, most smBGCs of <italic toggle="yes">Streptomyces</italic> are quite large, often exceeding 100&#x000a0;kbp, and the cloning of large-sized DNA is the major bottleneck (Miao et&#x000a0;al., <xref rid="bib67" ref-type="bibr">2005</xref>). In addition, the high GC content of the <italic toggle="yes">Streptomyces</italic> genome hampers the acquisition of whole smBGCs by PCR (McDowell et&#x000a0;al., <xref rid="bib64" ref-type="bibr">1998</xref>). Although direct pathway cloning, comprising PCR amplification of partial smBGCs and assembly of PCR products, has been exploited to clone smBGCs, its application has been limited to relatively short DNA fragments (&#x0223c;25&#x000a0;kbp) (Greunke et&#x000a0;al., <xref rid="bib23" ref-type="bibr">2018</xref>). Cloning of longer DNA requires screening target smBGCs from cosmid, fosmid, or BAC libraries bearing random genomic DNA fragments, which requires considerable labor and time (Miao et&#x000a0;al., <xref rid="bib67" ref-type="bibr">2005</xref>). To increase the selectivity of the target genomic fragment, homology-dependent cloning methods, particularly transformation-associated recombination (TAR) cloning, have been utilized (Zhang et&#x000a0;al., <xref rid="bib97" ref-type="bibr">2019</xref>). However, obtaining the precise smBGC region is a bottleneck. To overcome these limitations, the CRISPR/Cas system can be used <italic toggle="yes">in vitro</italic> to obtain smBGCs directly from the genome of <italic toggle="yes">Streptomyces</italic> (Fig.&#x000a0;<xref rid="fig4" ref-type="fig">4</xref>) (Jiang et&#x000a0;al., <xref rid="bib33" ref-type="bibr">2015</xref>). The major obstacle to capturing large DNA fragments <italic toggle="yes">in vitro</italic> is that genomic DNA is prone to shearing (Moore et&#x000a0;al., <xref rid="bib69" ref-type="bibr">1999</xref>). To minimize the shearing stress of genomic DNA during extraction and cleavage by the CRISPR/Cas system, the cells are immobilized in agarose plugs, and the lysis of the cells and cleavage of the genomic DNA by CRISPR/Cas9 is processed in a gel (Jiang et&#x000a0;al., <xref rid="bib33" ref-type="bibr">2015</xref>). Cas9 cleavage generates a blunt-end product; thus, Gibson assembly was used to ligate the DNA fragment into the cloning vector. To increase cloning efficiency, Cas12a, which generates sticky ends, can be used as an advanced alternative to Cas9 (Liang et&#x000a0;al., <xref rid="bib53" ref-type="bibr">2022</xref>). However, <italic toggle="yes">in vitro</italic> assembly of large DNA fragments may generate undesired by-products, such as DNA concatemers (Dugaiczyk et&#x000a0;al., <xref rid="bib17" ref-type="bibr">1975</xref>). To further elevate the efficiency of smBGC cloning, the smBGC fragment from Cas12a cleavage can be circularized via <italic toggle="yes">in vivo</italic> Cre-<italic toggle="yes">lox</italic> recombination (Enghiad et&#x000a0;al., <xref rid="bib18" ref-type="bibr">2021</xref>). First, two <italic toggle="yes">lox</italic>P sites are introduced at the both ends of the target smBGC fragment, along with either origin or selection marker required for maintaining the plasmid. The resulting linear DNA is then transformed into <italic toggle="yes">Escherichia coli</italic> harboring Cre-<italic toggle="yes">lox</italic> recombination system for <italic toggle="yes">in vivo</italic> circularization of the smBGC containing plasmid. This approach facilitated cloning of 47 different smBGCs ranging from 10 to 113&#x000a0;kbp.</p><p>Heterologous expression of smBGCs can be advantageous compared to engineering native-producing organisms, in that the complex transcriptional regulation of natural producers can be bypassed (Xu &#x00026; Wright, <xref rid="bib90" ref-type="bibr">2019</xref>). However, the genetic background of the expression host may not be suitable for the transcription of foreign smBGC; thus, appropriate refactoring of the promoters for the biosynthesis of genes may be required. Scarless and multiplexed DNA editing of nearly unrestricted target positions using the CRISPR/Cas system has enormous utility for refactoring smBGCs. In addition, the CRISPR/Cas system can be directly utilized to engineer smBGCs, especially by refactoring promoters in a heterologous expression host, which is well suited for CRISPR/Cas-mediated genetic engineering.</p></sec></sec><sec id="sec5"><title>Concluding Remarks and Future Perspectives</title><p>This review briefly summarizes the broad range of CRISPR/Cas applications in <italic toggle="yes">Streptomyces</italic> for natural product discovery and production. The genetic outcome of CRISPR/Cas-based engineering is the same as that of conventional double-crossover mediated genome editing. However, the dramatically reduced time and labor required for genetic manipulation opens the possibility of investigating an enormous amount of uncharacterized smBGCs and relieving the imbalance between smBGCs and secondary metabolite discovery (Kieser et&#x000a0;al., <xref rid="bib38" ref-type="bibr">2000</xref>; Lee et&#x000a0;al., <xref rid="bib43" ref-type="bibr">2020a</xref>). However, there remain obstacles and improvements for CRISPR/Cas applications in <italic toggle="yes">Streptomyces</italic>. As <italic toggle="yes">Streptomyces</italic> represents one of the largest genera of bacteria, it is difficult to establish common genetic engineering tools for all species, and every step in genetic manipulation may require optimization for each species (Kieser et&#x000a0;al., <xref rid="bib38" ref-type="bibr">2000</xref>). At present, only three types of CRISPR/Cas systems have been demonstrated for the genetic engineering of <italic toggle="yes">Streptomyces</italic>, and other types of CRISPR/Cas systems could be exploited to overcome the species-level heterogeneity of genetic engineering (Koonin et&#x000a0;al., <xref rid="bib40" ref-type="bibr">2017</xref>). In addition to expanding the available CRISPR/Cas systems, heterologous expression in genetically tractable and metabolically clean <italic toggle="yes">Streptomyces</italic> hosts can also be exploited (Fazal et&#x000a0;al., <xref rid="bib19" ref-type="bibr">2020</xref>). In particular, the use of a chassis strain and a uniform genetic manipulation protocol for heterologous expression enables the automation of experimental procedures (Yuan et&#x000a0;al., <xref rid="bib92" ref-type="bibr">2022</xref>). Although the CRISPR/Cas system dramatically reduced the time required for <italic toggle="yes">Streptomyces</italic> engineering, engineering smBGCs remains a bottleneck for secondary metabolite discovery compared to <italic toggle="yes">Streptomyces</italic> isolation and smBGC prediction (Lee et&#x000a0;al., <xref rid="bib43" ref-type="bibr">2020a</xref>). In this regard, the automation of experimental procedures, including cloning and refactoring of smBGCs, production in heterologous expression hosts, and identification of the synthesized molecule, is urgently needed to enable extensive investigation of uncharacterized smBGCs (Yuan et&#x000a0;al., <xref rid="bib92" ref-type="bibr">2022</xref>, <xref rid="bib93" ref-type="bibr">2023</xref>). Recently, new genetic engineering tools that harness the precise DNA-targeting ability of the CRISPR/Cas system have been developed and applied in <italic toggle="yes">Streptomyces</italic>. The CRISPR/Cas system fosters natural product research and is poised to become the basis for the a potential second &#x02018;golden era&#x02019; in antibiotic discovery.</p></sec></body><back><sec id="sec6"><title>Funding</title><p>This study was supported by the Bio &#x00026; Medical Technology Development Program [Grant No. 2021M3A9I5023245 to B-KC] of the National Research Foundation (NRF), funded by the Ministry of Science and ICT (MSIT). This work was also supported by a grant from the Novo Nordisk Foundation [Grant No. NNF10CC1016517 to BOP].</p></sec><sec sec-type="COI-statement" id="sec7"><title>Conflict of Interest</title><p>The authors declare that this study was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</p></sec><ref-list id="ref1"><title>References</title><ref id="bib1"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ameruoso</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Villegas Kcam</surname> &#x000a0;<given-names>M. C.</given-names></string-name>, <string-name><surname>Cohen</surname> &#x000a0;<given-names>K. P.</given-names></string-name>, <string-name><surname>Chappell</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Activating natural product synthesis using CRISPR interference and activation systems in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Nucleic Acids Research</source>, <volume>50</volume>(<issue>13</issue>), <fpage>7751</fpage>&#x02013;<lpage>7760</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac556</pub-id><pub-id pub-id-type="pmid">35801861</pub-id>
</mixed-citation></ref><ref id="bib2"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Anzalone</surname> &#x000a0;<given-names>A. V.</given-names></string-name>, <string-name><surname>Randolph</surname> &#x000a0;<given-names>P. B.</given-names></string-name>, <string-name><surname>Davis</surname> &#x000a0;<given-names>J. R.</given-names></string-name>, <string-name><surname>Sousa</surname> &#x000a0;<given-names>A. A.</given-names></string-name>, <string-name><surname>Koblan</surname> &#x000a0;<given-names>L. W.</given-names></string-name>, <string-name><surname>Levy</surname> &#x000a0;<given-names>J. M.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>P. J.</given-names></string-name>, <string-name><surname>Wilson</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Newby</surname> &#x000a0;<given-names>G. A.</given-names></string-name>, <string-name><surname>Raguram</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>D. R.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Search-and-replace genome editing without double-strand breaks or donor DNA</article-title>. <source>Nature</source>, <volume>576</volume>(<issue>7785</issue>), <fpage>149</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-019-1711-4</pub-id><pub-id pub-id-type="pmid">31634902</pub-id>
</mixed-citation></ref><ref id="bib3"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Arcamone</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Cassinelli</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Fantini</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Grein</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Orezzi</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Pol</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Spalla</surname> &#x000a0;<given-names>C.</given-names></string-name></person-group> (<year>1969</year>). <article-title>Adriamycin, 14-hydroxydaimomycin, a new antitumor antibiotic from <italic toggle="yes">S. Peucetius</italic> var. <italic toggle="yes">Caesius</italic></article-title>. <source>Biotechnology &#x00026; Bioengineering</source>, <volume>11</volume>(<issue>6</issue>), <fpage>1101</fpage>&#x02013;<lpage>1110</lpage>.<pub-id pub-id-type="pmid">5365804</pub-id>
</mixed-citation></ref><ref id="bib4"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bai</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>van Wezel</surname> &#x000a0;<given-names>G. P.</given-names></string-name></person-group> (<year>2023</year>). <article-title>CUBIC: A versatile cumate-based inducible CRISPRi system in <italic toggle="yes">Streptomyces</italic></article-title>. <source>ACS Synthetic Biology</source>, <volume>12</volume>, <fpage>3143</fpage>&#x02013;<lpage>3147</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.3c00464</pub-id><pub-id pub-id-type="pmid">37801665</pub-id>
</mixed-citation></ref><ref id="bib5"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Baral</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Akhgari</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Mets&#x000e4;-Ketel&#x000e4;</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Activation of microbial secondary metabolic pathways: Avenues and challenges</article-title>. <source>Synthetic and Systems Biotechnology</source>, <volume>3</volume>(<issue>3</issue>), <fpage>163</fpage>&#x02013;<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1016/j.synbio.2018.09.001</pub-id><pub-id pub-id-type="pmid">30345402</pub-id>
</mixed-citation></ref><ref id="bib6"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Beck</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Gren</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Ortiz-L&#x000f3;pez</surname> &#x000a0;<given-names>F. J.</given-names></string-name>, <string-name><surname>J&#x000f8;rgensen</surname> &#x000a0;<given-names>T. S.</given-names></string-name>, <string-name><surname>Carretero-Molina</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Serrano</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>J.</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>J.</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Oves-Costales</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Kontou</surname> &#x000a0;<given-names>E. E.</given-names></string-name>, <string-name><surname>Mohite</surname> &#x000a0;<given-names>O. S.</given-names></string-name>, <string-name><surname>Mingyar</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Stegmann</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Genilloud</surname> &#x000a0;<given-names>O.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T</given-names></string-name></person-group>. (<year>2021</year>). <article-title>Activation and identification of a Griseusin cluster in <italic toggle="yes">Streptomyces</italic> sp. CA-256286 by employing transcriptional regulators and multi-omics methods</article-title>. <source>Molecules (Basel, Switzerland)</source>, <volume>26</volume>(<issue>21</issue>), <fpage>6580</fpage>. <pub-id pub-id-type="doi">10.3390/molecules26216580</pub-id><pub-id pub-id-type="pmid">34770989</pub-id>
</mixed-citation></ref><ref id="bib7"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bode</surname> &#x000a0;<given-names>H. B.</given-names></string-name>, <string-name><surname>Bethe</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>H&#x000f6;fs</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Zeeck</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> (<year>2002</year>). <article-title>Big effects from small changes: Possible ways to explore nature's chemical diversity</article-title>. <source>ChemBioChem</source>, <volume>3</volume>(<issue>7</issue>), <fpage>619</fpage>&#x02013;<lpage>627</lpage>.<pub-id pub-id-type="pmid">12324995</pub-id>
</mixed-citation></ref><ref id="bib8"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Boucher</surname> &#x000a0;<given-names>H. W.</given-names></string-name>, <string-name><surname>Talbot</surname> &#x000a0;<given-names>G. H.</given-names></string-name>, <string-name><surname>Bradley</surname> &#x000a0;<given-names>J. S.</given-names></string-name>, <string-name><surname>Edwards</surname> &#x000a0;<given-names>J. E.</given-names></string-name>, <string-name><surname>Gilbert</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Rice</surname> &#x000a0;<given-names>L. B.</given-names></string-name>, <string-name><surname>Scheld</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Spellberg</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Bartlett</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> (<year>2009</year>). <article-title>Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America</article-title>. <source>Clinical Infectious Diseases</source>, <volume>48</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">19035777</pub-id>
</mixed-citation></ref><ref id="bib9"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Bu</surname> &#x000a0;<given-names>Q. T.</given-names></string-name>, <string-name><surname>Yu</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Z. Y.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>X. A.</given-names></string-name>, <string-name><surname>Mao</surname> &#x000a0;<given-names>X. M.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Y. Q.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Rational construction of genome-reduced and high-efficient industrial <italic toggle="yes">Streptomyces</italic> chassis based on multiple comparative genomic approaches</article-title>. <source>Microbial Cell Factories</source>, <volume>18</volume>(<issue>1</issue>), <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-019-1055-7</pub-id><pub-id pub-id-type="pmid">30691531</pub-id>
</mixed-citation></ref><ref id="bib10"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Burg</surname> &#x000a0;<given-names>R. W.</given-names></string-name>, <string-name><surname>Miller</surname> &#x000a0;<given-names>B. M.</given-names></string-name>, <string-name><surname>Baker</surname> &#x000a0;<given-names>E. E.</given-names></string-name>, <string-name><surname>Birnbaum</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Currie</surname> &#x000a0;<given-names>S. A.</given-names></string-name>, <string-name><surname>Hartman</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Kong</surname> &#x000a0;<given-names>Y. L.</given-names></string-name>, <string-name><surname>Monaghan</surname> &#x000a0;<given-names>R. L.</given-names></string-name>, <string-name><surname>Olson</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Putter</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Tunac</surname> &#x000a0;<given-names>J. B.</given-names></string-name>, <string-name><surname>Wallick</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Stapley</surname> &#x000a0;<given-names>E. O.</given-names></string-name>, <string-name><surname>Oiwa</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>&#x0014c;mura</surname> &#x000a0;<given-names>S.</given-names></string-name></person-group> (<year>1979</year>). <article-title>Avermectins, new family of potent anthelmintic agents: Producing organism and fermentation</article-title>. <source>Antimicrobial Agents and Chemotherapy</source>, <volume>15</volume>(<issue>3</issue>), <fpage>361</fpage>&#x02013;<lpage>367</lpage>.<pub-id pub-id-type="pmid">464561</pub-id>
</mixed-citation></ref><ref id="bib11"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Chater</surname> &#x000a0;<given-names>K. F.</given-names></string-name>, <string-name><surname>Chandra</surname> &#x000a0;<given-names>G.</given-names></string-name></person-group> (<year>2008</year>). <article-title>The use of the rare UUA codon to define &#x0201c;Expression Space&#x0201d; for genes involved in secondary metabolism, development and environmental adaptation in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Journal of Microbiology</source>, <volume>46</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s12275-007-0233-1</pub-id><pub-id pub-id-type="pmid">18337685</pub-id>
</mixed-citation></ref><ref id="bib12"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cho</surname> &#x000a0;<given-names>M. K.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>B. T.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>H. U.</given-names></string-name>, <string-name><surname>Oh</surname> &#x000a0;<given-names>M. K.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Systems metabolic engineering of <italic toggle="yes">Streptomyces venezuelae</italic> for the enhanced production of pikromycin</article-title>. <source>Biotechnology &#x00026; Bioengineering</source>, <volume>119</volume>(<issue>8</issue>), <fpage>2250</fpage>&#x02013;<lpage>2260</lpage>. <pub-id pub-id-type="doi">10.1002/bit.28114</pub-id><pub-id pub-id-type="pmid">35445397</pub-id>
</mixed-citation></ref><ref id="bib13"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Cobb</surname> &#x000a0;<given-names>R. E.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2015</year>). <article-title>High-efficiency multiplex genome editing of <italic toggle="yes">Streptomyces</italic> species using an engineered CRISPR/Cas system</article-title>. <source>ACS Synthetic Biology</source>, <volume>4</volume>(<issue>6</issue>), <fpage>723</fpage>&#x02013;<lpage>728</lpage>.<pub-id pub-id-type="pmid">25458909</pub-id>
</mixed-citation></ref><ref id="bib14"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Craney</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Ahmed</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Nodwell</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> (<year>2013</year>). <article-title>Towards a new science of secondary metabolism</article-title>. <source>Journal of Antibiotics</source>, <volume>66</volume>(<issue>7</issue>), <fpage>387</fpage>&#x02013;<lpage>400</lpage>.<pub-id pub-id-type="pmid">23612726</pub-id>
</mixed-citation></ref><ref id="bib15"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dervyn</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Planson</surname> &#x000a0;<given-names>A.-G.</given-names></string-name>, <string-name><surname>Tanaka</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Chubukov</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Gu&#x000e9;rin</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Derozier</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Lecointe</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Sauer</surname> &#x000a0;<given-names>U.</given-names></string-name>, <string-name><surname>Yoshida</surname> &#x000a0;<given-names>K.-I.</given-names></string-name>, <string-name><surname>Nicolas</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Noirot</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Jules</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Greedy reduction of <italic toggle="yes">Bacillus subtilis</italic> genome yields emergent phenotypes of high resistance to a DNA damaging agent and low evolvability</article-title>. <source>Nucleic Acids Research</source>, <volume>51</volume>(<issue>6</issue>), <fpage>2974</fpage>&#x02013;<lpage>2992</lpage>.<pub-id pub-id-type="pmid">36919610</pub-id>
</mixed-citation></ref><ref id="bib16"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Doudna</surname> &#x000a0;<given-names>J. A.</given-names></string-name>, <string-name><surname>Charpentier</surname> &#x000a0;<given-names>E.</given-names></string-name></person-group> (<year>2014</year>). <article-title>The new frontier of genome engineering with CRISPR-Cas9</article-title>. <source>Science</source>, <volume>346</volume>(<issue>6213</issue>), <fpage>1258096</fpage>.<pub-id pub-id-type="pmid">25430774</pub-id>
</mixed-citation></ref><ref id="bib17"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Dugaiczyk</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Boyer</surname> &#x000a0;<given-names>H. W.</given-names></string-name>, <string-name><surname>Goodman</surname> &#x000a0;<given-names>H. M.</given-names></string-name></person-group> (<year>1975</year>). <article-title>Ligation of <italic toggle="yes">Eco</italic>RI endonuclease-generated DNA fragments into linear and circular structures</article-title>. <source>Journal of Molecular Biology</source>, <volume>96</volume>(<issue>1</issue>), <fpage>171</fpage>&#x02013;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1016/0022-2836(75)90189-8</pub-id><pub-id pub-id-type="pmid">169355</pub-id>
</mixed-citation></ref><ref id="bib18"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Enghiad</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Huang</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Guo</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Tabatabaei</surname> &#x000a0;<given-names>S. K.</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>T. A.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Cas12a-assisted precise targeted cloning using <italic toggle="yes">in vivo</italic> cre-<italic toggle="yes">lox</italic> recombination</article-title>. <source>Nature Communications</source>, <volume>12</volume>(<issue>1</issue>), <fpage>1171</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-021-21275-4</pub-id></mixed-citation></ref><ref id="bib19"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fazal</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Thankachan</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Harris</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Seipke</surname> &#x000a0;<given-names>R. F.</given-names></string-name></person-group> (<year>2020</year>). <article-title>A chromatogram-simplified <italic toggle="yes">Streptomyces albus</italic> host for heterologous production of natural products</article-title>. <source>Antonie Van Leeuwenhoek</source>, <volume>113</volume>, <fpage>511</fpage>&#x02013;<lpage>520</lpage>.<pub-id pub-id-type="pmid">31781915</pub-id>
</mixed-citation></ref><ref id="bib20"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Fontana</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Dong</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Kiattisewee</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Chavali</surname> &#x000a0;<given-names>V. P.</given-names></string-name>, <string-name><surname>Tickman</surname> &#x000a0;<given-names>B. I.</given-names></string-name>, <string-name><surname>Carothers</surname> &#x000a0;<given-names>J. M.</given-names></string-name>, <string-name><surname>Zalatan</surname> &#x000a0;<given-names>J. G.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Effective CRISPRa-mediated control of gene expression in bacteria must overcome strict target site requirements</article-title>. <source>Nature Communications</source>, <volume>11</volume>(<issue>1</issue>), <fpage>1618</fpage>.</mixed-citation></ref><ref id="bib21"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gilbert</surname> &#x000a0;<given-names>L. A.</given-names></string-name>, <string-name><surname>Horlbeck</surname> &#x000a0;<given-names>M. A.</given-names></string-name>, <string-name><surname>Adamson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Villalta</surname> &#x000a0;<given-names>J. E.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Whitehead</surname> &#x000a0;<given-names>E. H.</given-names></string-name>, <string-name><surname>Guimaraes</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Panning</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Ploegh</surname> &#x000a0;<given-names>H. L.</given-names></string-name>, <string-name><surname>Bassik</surname> &#x000a0;<given-names>M. C.</given-names></string-name>, <string-name><surname>Qi</surname> &#x000a0;<given-names>L. S.</given-names></string-name>, <string-name><surname>Kampmann</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Weissman</surname> &#x000a0;<given-names>J. S.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Genome-scale CRISPR-mediated control of gene repression and activation</article-title>. <source>Cell</source>, <volume>159</volume>(<issue>3</issue>), <fpage>647</fpage>&#x02013;<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.09.029</pub-id><pub-id pub-id-type="pmid">25307932</pub-id>
</mixed-citation></ref><ref id="bib22"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Gren</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Whitford</surname> &#x000a0;<given-names>C. M.</given-names></string-name>, <string-name><surname>Mohite</surname> &#x000a0;<given-names>O. S.</given-names></string-name>, <string-name><surname>J&#x000f8;rgensen</surname> &#x000a0;<given-names>T. S.</given-names></string-name>, <string-name><surname>Kontou</surname> &#x000a0;<given-names>E. E.</given-names></string-name>, <string-name><surname>Nielsen</surname> &#x000a0;<given-names>J. B.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>S. Y.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Characterization and engineering of <italic toggle="yes">Streptomyces griseofuscus</italic> DSM 40191 as a potential host for heterologous expression of biosynthetic gene clusters</article-title>. <source>Scientific Reports</source>, <volume>11</volume>(<issue>1</issue>), <fpage>18301</fpage>.<pub-id pub-id-type="pmid">34526549</pub-id>
</mixed-citation></ref><ref id="bib23"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Greunke</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Duell</surname> &#x000a0;<given-names>E. R.</given-names></string-name>, <string-name><surname>D'Agostino</surname> &#x000a0;<given-names>P. M.</given-names></string-name>, <string-name><surname>Gl&#x000f6;ckle</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Lamm</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Gulder</surname> &#x000a0;<given-names>T. A. M.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Direct pathway cloning (DiPaC) to unlock natural product biosynthetic potential</article-title>. <source>Metabolic Engineering</source>, <volume>47</volume>, <fpage>334</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2018.03.010</pub-id><pub-id pub-id-type="pmid">29548983</pub-id>
</mixed-citation></ref><ref id="bib24"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>He</surname> &#x000a0;<given-names>J. M.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G. S.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>P. P.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>G. P.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>G. Q.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W. H.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y. H.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Direct involvement of the master nitrogen metabolism regulator GlnR in antibiotic biosynthesis in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Journal of Biological Chemistry</source>, <volume>291</volume>(<issue>51</issue>), <fpage>26443</fpage>&#x02013;<lpage>26454</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M116.762476</pub-id><pub-id pub-id-type="pmid">27875313</pub-id>
</mixed-citation></ref><ref id="bib25"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Heng</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. W.</given-names></string-name>, <string-name><surname>Leong</surname> &#x000a0;<given-names>C. Y.</given-names></string-name>, <string-name><surname>Ng</surname> &#x000a0;<given-names>V. W. P.</given-names></string-name>, <string-name><surname>Ng</surname> &#x000a0;<given-names>S. B.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. H.</given-names></string-name>, <string-name><surname>Wong</surname> &#x000a0;<given-names>F. T.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Enhancing armeniaspirols production through multi-level engineering of a native <italic toggle="yes">Streptomyces</italic> producer</article-title>. <source>Microbial Cell Factories</source>, <volume>22</volume>(<issue>1</issue>), <fpage>84</fpage>. <pub-id pub-id-type="doi">10.1186/s12934-023-02092-4</pub-id><pub-id pub-id-type="pmid">37118806</pub-id>
</mixed-citation></ref><ref id="bib26"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hoff</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Bertrand</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Piotrowski</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Thibessard</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Leblond</surname> &#x000a0;<given-names>P.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Genome plasticity is governed by double strand break DNA repair in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Scientific Reports</source>, <volume>8</volume>(<issue>1</issue>), <fpage>5272</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-23622-w</pub-id><pub-id pub-id-type="pmid">29588483</pub-id>
</mixed-citation></ref><ref id="bib27"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hou</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Zou</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Ye</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2021</year>). <article-title>A putative redox-sensing regulator Rex regulates lincomycin biosynthesis in <italic toggle="yes">Streptomyces lincolnensis</italic></article-title>. <source>Journal of Basic Microbiology</source>, <volume>61</volume>(<issue>9</issue>), <fpage>772</fpage>&#x02013;<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1002/jobm.202100249</pub-id><pub-id pub-id-type="pmid">34313330</pub-id>
</mixed-citation></ref><ref id="bib28"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Huang</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Hu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2015</year>). <article-title>One-step high-efficiency CRISPR/Cas9-mediated genome editing in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Acta Biochimica et Biophysica Sinica</source>, <volume>47</volume>(<issue>4</issue>), <fpage>231</fpage>&#x02013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmv007</pub-id><pub-id pub-id-type="pmid">25739462</pub-id>
</mixed-citation></ref><ref id="bib29"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Hwang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B.-K.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Repurposing modular polyketide synthases and non-ribosomal peptide synthetases for novel chemical biosynthesis</article-title>. <source>Frontiers Molecular Biosciences.</source>, <volume>7</volume>, <fpage>87</fpage>.</mixed-citation></ref><ref id="bib30"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jeon</surname> &#x000a0;<given-names>C. W.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>D. R.</given-names></string-name>, <string-name><surname>Kwak</surname> &#x000a0;<given-names>Y. S.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Valinomycin, produced by <italic toggle="yes">Streptomyces</italic> sp. S8, a key antifungal metabolite in large patch disease suppressiveness</article-title>. <source>World Journal of Microbiology and Biotechnology</source>, <volume>35</volume>(<issue>8</issue>), <fpage>128</fpage>. <pub-id pub-id-type="doi">10.1007/s11274-019-2704-z</pub-id><pub-id pub-id-type="pmid">31375920</pub-id>
</mixed-citation></ref><ref id="bib31"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ji</surname> &#x000a0;<given-names>C. H.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Je</surname> &#x000a0;<given-names>H. W.</given-names></string-name>, <string-name><surname>Kwon</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Kang</surname> &#x000a0;<given-names>H. S.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Top-down synthetic biology approach for titer improvement of clinically important antibiotic daptomycin in <italic toggle="yes">Streptomyces roseosporus</italic></article-title>. <source>Metabolic Engineering</source>, <volume>69</volume>, <fpage>40</fpage>&#x02013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2021.10.013</pub-id><pub-id pub-id-type="pmid">34737068</pub-id>
</mixed-citation></ref><ref id="bib32"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jia</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Han</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Tang</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Development of a CRISPR/Cas9-mediated gene-editing tool in <italic toggle="yes">Streptomyces rimosus</italic></article-title>. <source>Microbiology (Reading, England)</source>, <volume>163</volume>(<issue>8</issue>), <fpage>1148</fpage>&#x02013;<lpage>1155</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.000501</pub-id><pub-id pub-id-type="pmid">28742008</pub-id>
</mixed-citation></ref><ref id="bib33"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Gabrieli</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Lou</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Ebenstein</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>T. F.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Cas9-Assisted targeting of CHromosome segments CATCH enables one-step targeted cloning of large gene clusters</article-title>. <source>Nature Communications</source>, <volume>6</volume>, <fpage>8101</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9101</pub-id></mixed-citation></ref><ref id="bib34"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jiang</surname> &#x000a0;<given-names>Y. H.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Y. F.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>J. Y.</given-names></string-name>, <string-name><surname>Guo</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>Q. W.</given-names></string-name>, <string-name><surname>Mao</surname> &#x000a0;<given-names>X. M.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Fine-tuning Cas9 activity with a cognate inhibitor AcrIIA4 to improve genome editing in <italic toggle="yes">Streptomyces</italic></article-title>. <source>ACS Synthetic Biology</source>, <volume>10</volume>(<issue>11</issue>), <fpage>2833</fpage>&#x02013;<lpage>2841</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.1c00141</pub-id><pub-id pub-id-type="pmid">34734710</pub-id>
</mixed-citation></ref><ref id="bib35"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Jinek</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Chylinski</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Fonfara</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Hauer</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Doudna</surname> &#x000a0;<given-names>J. A.</given-names></string-name>, <string-name><surname>Charpentier</surname> &#x000a0;<given-names>E.</given-names></string-name></person-group> (<year>2012</year>). <article-title>A programmable dual-RNA&#x02013;guided DNA endonuclease in adaptive bacterial immunity</article-title>. <source>Science</source>, <volume>337</volume>(<issue>6096</issue>), <fpage>816</fpage>&#x02013;<lpage>821</lpage>.<pub-id pub-id-type="pmid">22745249</pub-id>
</mixed-citation></ref><ref id="bib36"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kang</surname> &#x000a0;<given-names>H.-S.</given-names></string-name>, <string-name><surname>Charlop-Powers</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Brady</surname> &#x000a0;<given-names>S. F.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Multiplexed CRISPR/Cas9-and TAR-mediated promoter engineering of natural product biosynthetic gene clusters in yeast</article-title>. <source>ACS Synthetic Biology</source>, <volume>5</volume>(<issue>9</issue>), <fpage>1002</fpage>&#x02013;<lpage>1010</lpage>.<pub-id pub-id-type="pmid">27197732</pub-id>
</mixed-citation></ref><ref id="bib37"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Khattab</surname> &#x000a0;<given-names>A. I.</given-names></string-name>, <string-name><surname>Babiker</surname> &#x000a0;<given-names>E. H.</given-names></string-name>, <string-name><surname>Saeed</surname> &#x000a0;<given-names>H. A.</given-names></string-name></person-group> (<year>2016</year>). <article-title><italic toggle="yes">Streptomyces</italic>: Isolation, optimization of culture conditions and extraction of secondary metabolites</article-title>. <source>International Current Pharmaceutical Journal</source>, <volume>5</volume>(<issue>3</issue>), <fpage>27</fpage>&#x02013;<lpage>32</lpage>.</mixed-citation></ref><ref id="bib38"><mixed-citation publication-type="book">
<person-group person-group-type="author">
<string-name>
<surname>Kieser</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Bibb</surname> &#x000a0;<given-names>M. J.</given-names></string-name>, <string-name><surname>Buttner</surname> &#x000a0;<given-names>M. J.</given-names></string-name>, <string-name><surname>Chater</surname> &#x000a0;<given-names>K. F.</given-names></string-name>, <string-name><surname>Hopwood</surname> &#x000a0;<given-names>D. A.</given-names></string-name></person-group> (<year>2000</year>). <source>Practical Streptomyces Genetics</source>. (Vol. <volume>291</volume>). <publisher-name>John Innes Foundation Norwich</publisher-name>.</mixed-citation></ref><ref id="bib39"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Kim</surname> &#x000a0;<given-names>D. R.</given-names></string-name>, <string-name><surname>Kwak</surname> &#x000a0;<given-names>Y. S.</given-names></string-name></person-group> (<year>2021</year>). <article-title>A genome-wide analysis of antibiotic producing genes in <italic toggle="yes">Streptomyces globisporus</italic> SP6C4</article-title>. <source>Plant Pathology Journal</source>, <volume>37</volume>(<issue>5</issue>), <fpage>503</fpage>. <pub-id pub-id-type="doi">10.5423/PPJ.ER.03.2021.0047</pub-id><pub-id pub-id-type="pmid">34847638</pub-id>
</mixed-citation></ref><ref id="bib40"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Koonin</surname> &#x000a0;<given-names>E. V.</given-names></string-name>, <string-name><surname>Makarova</surname> &#x000a0;<given-names>K. S.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Diversity, classification and evolution of CRISPR-Cas systems</article-title>. <source>Current Opinion in Microbiology</source>, <volume>37</volume>, <fpage>67</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.mib.2017.05.008</pub-id><pub-id pub-id-type="pmid">28605718</pub-id>
</mixed-citation></ref><ref id="bib41"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Larson</surname> &#x000a0;<given-names>M. H.</given-names></string-name>, <string-name><surname>Gilbert</surname> &#x000a0;<given-names>L. A.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>W. A.</given-names></string-name>, <string-name><surname>Weissman</surname> &#x000a0;<given-names>J. S.</given-names></string-name>, <string-name><surname>Qi</surname> &#x000a0;<given-names>L. S.</given-names></string-name></person-group> (<year>2013</year>). <article-title>CRISPR interference (CRISPRi) for sequence-specific control of gene expression</article-title>. <source>Nature Protocols</source>, <volume>8</volume>(<issue>11</issue>), <fpage>2180</fpage>&#x02013;<lpage>2196</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2013.132</pub-id><pub-id pub-id-type="pmid">24136345</pub-id>
</mixed-citation></ref><ref id="bib42"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Choi</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Hwang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>J. H.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>S. C.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Jang</surname> &#x000a0;<given-names>K. S.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B. K.</given-names></string-name></person-group> (<year>2021</year>). <article-title>Re-classification of <italic toggle="yes">Streptomyces venezuelae</italic> strains and mining secondary metabolite biosynthetic gene clusters</article-title>. <source>IScience</source>, <volume>24</volume>(<issue>12</issue>), <fpage>103410</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2021.103410</pub-id><pub-id pub-id-type="pmid">34877485</pub-id>
</mixed-citation></ref><ref id="bib43"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Hwang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B. K.</given-names></string-name></person-group> (<year>2020a</year>). <article-title>Thirty complete <italic toggle="yes">Streptomyces</italic> genome sequences for mining novel secondary metabolite biosynthetic gene clusters</article-title>. <source>Scientific Data</source>, <volume>7</volume>(<issue>1</issue>), <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1038/s41597-020-0395-9</pub-id><pub-id pub-id-type="pmid">32054853</pub-id>
</mixed-citation></ref><ref id="bib44"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Hwang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B. O.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B.-K.</given-names></string-name></person-group> (<year>2020b</year>). <article-title>System-level understanding of gene expression and regulation for engineering secondary metabolite production in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Journal of Industrial Microbiology Biotechnology</source>, <volume>47</volume>(<issue>9&#x02013;10</issue>), <fpage>739</fpage>&#x02013;<lpage>752</lpage>.<pub-id pub-id-type="pmid">32778981</pub-id>
</mixed-citation></ref><ref id="bib45"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Hwang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B.-K.</given-names></string-name></person-group> (<year>2020c</year>). <article-title>Mini review: Genome mining approaches for the identification of secondary metabolite biosynthetic gene clusters in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Computational and Structural Biotechnology Journal</source>, <volume>18</volume>, <fpage>1548</fpage>&#x02013;<lpage>1556</lpage>.<pub-id pub-id-type="pmid">32637051</pub-id>
</mixed-citation></ref><ref id="bib46"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lee</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Chung</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Jang</surname> &#x000a0;<given-names>K. S.</given-names></string-name>, <string-name><surname>Kim</surname> &#x000a0;<given-names>S. C.</given-names></string-name>, <string-name><surname>Palsson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Cho</surname> &#x000a0;<given-names>B. K.</given-names></string-name></person-group> (<year>2020d</year>). <article-title>Iron competition triggers antibiotic biosynthesis in <italic toggle="yes">Streptomyces coelicolor</italic> during coculture with <italic toggle="yes">Myxococcus xanthus</italic></article-title>. <source>The ISME Journal</source>, <volume>14</volume>(<issue>5</issue>), <fpage>1111</fpage>&#x02013;<lpage>1124</lpage>. <pub-id pub-id-type="doi">10.1038/s41396-020-0594-6</pub-id><pub-id pub-id-type="pmid">31992858</pub-id>
</mixed-citation></ref><ref id="bib47"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lewis</surname> &#x000a0;<given-names>K.</given-names></string-name>
</person-group> (<year>2013</year>). <article-title>Platforms for antibiotic discovery</article-title>. <source>Nature Review Drug Discovery</source>, <volume>12</volume>(<issue>5</issue>), <fpage>371</fpage>&#x02013;<lpage>387</lpage>.<pub-id pub-id-type="pmid">23629505</pub-id>
</mixed-citation></ref><ref id="bib48"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Gao</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Cui</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Pan</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>G.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Remarkable enhancement of bleomycin production through precise amplification of its biosynthetic gene cluster in <italic toggle="yes">Streptomyces verticillus</italic></article-title>. <source>Science China Life Sciences</source>, <volume>65</volume>(<issue>6</issue>), <fpage>1248</fpage>&#x02013;<lpage>1256</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-021-1998-8</pub-id><pub-id pub-id-type="pmid">34668129</pub-id>
</mixed-citation></ref><ref id="bib49"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Wei</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2018</year>). <article-title>CRISPR-Cpf1-assisted multiplex genome editing and transcriptional repression in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Applied and Environmental Microbiology</source>, <volume>84</volume>(<issue>18</issue>), <fpage>00827</fpage>. <pub-id pub-id-type="doi">10.1128/AEM.00827-18</pub-id></mixed-citation></ref><ref id="bib50"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Ge</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Multiplexed site-specific genome engineering for overproducing bioactive secondary metabolites in actinomycetes</article-title>. <source>Metabolic Engineering</source>, <volume>40</volume>, <fpage>80</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">28088540</pub-id>
</mixed-citation></ref><ref id="bib51"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Q.</given-names></string-name>, <string-name><surname>Zhong</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Deng</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Sun</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2020a</year>). <article-title>Exploration of hygromycin B biosynthesis utilizing CRISPR-Cas9-associated base editing</article-title>. <source>ACS Chemical Biology</source>, <volume>15</volume>(<issue>6</issue>), <fpage>1417</fpage>&#x02013;<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.0c00071</pub-id><pub-id pub-id-type="pmid">32275383</pub-id>
</mixed-citation></ref><ref id="bib52"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Li</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Ma</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Tao</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2020b</year>). <article-title>The orphan histidine kinase PdtaS-p regulates both morphological differentiation and antibiotic biosynthesis together with the orphan response regulator PdtaR-p in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Microbiological Research</source>, <volume>233</volume>, <fpage>126411</fpage>. <pub-id pub-id-type="doi">10.1016/j.micres.2020.126411</pub-id><pub-id pub-id-type="pmid">31981905</pub-id>
</mixed-citation></ref><ref id="bib53"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liang</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Zeng</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Karthik</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Bai</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Tong</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L. X.</given-names></string-name>, <string-name><surname>Tan</surname> &#x000a0;<given-names>G. Y.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Activating cryptic biosynthetic gene cluster through a CRISPR-Cas12a-mediated direct cloning approach</article-title>. <source>Nucleic Acids Research</source>, <volume>50</volume>(<issue>6</issue>), <fpage>3581</fpage>&#x02013;<lpage>3592</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkac181</pub-id><pub-id pub-id-type="pmid">35323947</pub-id>
</mixed-citation></ref><ref id="bib54"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lim</surname> &#x000a0;<given-names>Y. H.</given-names></string-name>, <string-name><surname>Wong</surname> &#x000a0;<given-names>F. T.</given-names></string-name>, <string-name><surname>Yeo</surname> &#x000a0;<given-names>W. L.</given-names></string-name>, <string-name><surname>Ching</surname> &#x000a0;<given-names>K. C.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. W.</given-names></string-name>, <string-name><surname>Heng</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Tsai</surname> &#x000a0;<given-names>D.-J.</given-names></string-name>, <string-name><surname>Lauderdale</surname> &#x000a0;<given-names>T.-L.</given-names></string-name>, <string-name><surname>Shia</surname> &#x000a0;<given-names>K.-S.</given-names></string-name>, <string-name><surname>Ho</surname> &#x000a0;<given-names>Y. S.</given-names></string-name>, <string-name><surname>Hoon</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Ang</surname> &#x000a0;<given-names>E. L.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>M. M.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Auroramycin: A potent antibiotic from <italic toggle="yes">Streptomyces roseosporus</italic> by CRISPR-Cas9 activation</article-title>. <source>ChemBioChem</source>, <volume>19</volume>(<issue>16</issue>), <fpage>1716</fpage>&#x02013;<lpage>1719</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201800266</pub-id></mixed-citation></ref><ref id="bib55"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Cheng</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Lyu</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Wen</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>Z.</given-names></string-name></person-group> (<year>2019a</year>). <article-title>AveI, an AtrA homolog of <italic toggle="yes">Streptomyces avermitilis</italic>, controls avermectin and oligomycin production, melanogenesis, and morphological differentiation</article-title>. <source>Applied Microbiology and Biotechnology</source>, <volume>103</volume>, <fpage>8459</fpage>&#x02013;<lpage>8472</lpage>.<pub-id pub-id-type="pmid">31422450</pub-id>
</mixed-citation></ref><ref id="bib56"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Metabolic engineering of <italic toggle="yes">Streptomyces coelicolor</italic> for enhanced prodigiosins (RED) production</article-title>. <source>Science China Life Sciiences</source>, <volume>60</volume>(<issue>9</issue>), <fpage>948</fpage>&#x02013;<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1007/s11427-017-9117-x</pub-id></mixed-citation></ref><ref id="bib57"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Liu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Wan</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>B.</given-names></string-name></person-group> (<year>2019b</year>). <article-title>Engineered CRISPRa enables programmable eukaryote-like gene activation in bacteria</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), <fpage>3693</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-11479-0</pub-id></mixed-citation></ref><ref id="bib58"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Low</surname> &#x000a0;<given-names>Z. J.</given-names></string-name>, <string-name><surname>Pang</surname> &#x000a0;<given-names>L. M.</given-names></string-name>, <string-name><surname>Ding</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Cheang</surname> &#x000a0;<given-names>Q. W.</given-names></string-name>, <string-name><surname>Le Mai Hoang</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Thi Tran</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X. W.</given-names></string-name>, <string-name><surname>Kanagasundaram</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Liang</surname> &#x000a0;<given-names>Z. X.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Identification of a biosynthetic gene cluster for the polyene macrolactam sceliphrolactam in a <italic toggle="yes">Streptomyces</italic> strain isolated from mangrove sediment</article-title>. <source>Scientific Reports</source>, <volume>8</volume>(<issue>1</issue>), <fpage>1594</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-20018-8</pub-id><pub-id pub-id-type="pmid">29371699</pub-id>
</mixed-citation></ref><ref id="bib59"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Lussier</surname> &#x000a0;<given-names>F. X.</given-names></string-name>, <string-name><surname>Denis</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Shareck</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> (<year>2010</year>). <article-title>Adaptation of the highly productive T7 expression system to <italic toggle="yes">Streptomyces lividans</italic></article-title>. <source>Applied and Environmental Microbiology</source>, <volume>76</volume>(<issue>3</issue>), <fpage>967</fpage>&#x02013;<lpage>970</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.02186-09</pub-id><pub-id pub-id-type="pmid">20023105</pub-id>
</mixed-citation></ref><ref id="bib60"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Ma</surname> &#x000a0;<given-names>J. X.</given-names></string-name>, <string-name><surname>He</surname> &#x000a0;<given-names>W. Y.</given-names></string-name>, <string-name><surname>Hua</surname> &#x000a0;<given-names>H. M.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>Q.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G. S.</given-names></string-name>, <string-name><surname>Zimin</surname> &#x000a0;<given-names>A. A.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>W. F.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y. H.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Development of a CRISPR/Cas9<sup>D10A</sup> Nickase (nCas9)-mediated genome editing tool in <italic toggle="yes">Streptomyces</italic></article-title>. <source>ACS Synthetic Biology</source>, <volume>12</volume>(<issue>10</issue>), <fpage>3114</fpage>&#x02013;<lpage>3123</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.3c00466</pub-id><pub-id pub-id-type="pmid">37722085</pub-id>
</mixed-citation></ref><ref id="bib61"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Maeder</surname> &#x000a0;<given-names>M. L.</given-names></string-name>, <string-name><surname>Linder</surname> &#x000a0;<given-names>S. J.</given-names></string-name>, <string-name><surname>Cascio</surname> &#x000a0;<given-names>V. M.</given-names></string-name>, <string-name><surname>Fu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Ho</surname> &#x000a0;<given-names>Q. H.</given-names></string-name>, <string-name><surname>Joung</surname> &#x000a0;<given-names>J. K.</given-names></string-name></person-group> (<year>2013</year>). <article-title>CRISPR RNA-guided activation of endogenous human genes</article-title>. <source>Nature Methods</source>, <volume>10</volume>(<issue>10</issue>), <fpage>977</fpage>&#x02013;<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2598</pub-id><pub-id pub-id-type="pmid">23892898</pub-id>
</mixed-citation></ref><ref id="bib62"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Magad&#x000e1;n-Corpas</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Ye</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>P&#x000e9;rez-Valero</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>McAlpine</surname> &#x000a0;<given-names>P. L.</given-names></string-name>, <string-name><surname>Vald&#x000e9;s-Chiara</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Torres-Bacete</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Nogales</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Villar</surname> &#x000a0;<given-names>C. J.</given-names></string-name>, <string-name><surname>Lomb&#x000f3;</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Optimized de novo eriodictyol biosynthesis in <italic toggle="yes">Streptomyces albidoflavus</italic> using an expansion of the golden standard toolkit for its use in actinomycetes</article-title>. <source>International Journal of Molecular Sciences</source>, <volume>24</volume>(<issue>10</issue>), <fpage>8879</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24108879</pub-id><pub-id pub-id-type="pmid">37240225</pub-id>
</mixed-citation></ref><ref id="bib63"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Marmann</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Aly</surname> &#x000a0;<given-names>A. H.</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Proksch</surname> &#x000a0;<given-names>P.</given-names></string-name></person-group> (<year>2014</year>). <article-title>Co-cultivation&#x02014;A powerful emerging tool for enhancing the chemical diversity of microorganisms</article-title>. <source>Marine Drugs</source>, <volume>12</volume>(<issue>2</issue>), <fpage>1043</fpage>&#x02013;<lpage>1065</lpage>.<pub-id pub-id-type="pmid">24549204</pub-id>
</mixed-citation></ref><ref id="bib64"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>McDowell</surname> &#x000a0;<given-names>D. G.</given-names></string-name>, <string-name><surname>Burns</surname> &#x000a0;<given-names>N. A.</given-names></string-name>, <string-name><surname>Parkes</surname> &#x000a0;<given-names>H. C.</given-names></string-name></person-group> (<year>1998</year>). <article-title>Localised sequence regions possessing high melting temperatures prevent the amplification of a DNA mimic in competitive PCR</article-title>. <source>Nucleic Acids Research</source>, <volume>26</volume>(<issue>14</issue>), <fpage>3340</fpage>&#x02013;<lpage>3347</lpage>.<pub-id pub-id-type="pmid">9649616</pub-id>
</mixed-citation></ref><ref id="bib65"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Meng</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Feng</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Zheng</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Ge</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Mast</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Wohlleben</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Gao</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Improvement of pristinamycin I (PI) production in <italic toggle="yes">Streptomyces pristinaespiralis</italic> by metabolic engineering approaches</article-title>. <source>Synthetic and Systems Biotechnology</source>, <volume>2</volume>(<issue>2</issue>), <fpage>130</fpage>&#x02013;<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1016/j.synbio.2017.06.001</pub-id><pub-id pub-id-type="pmid">29062970</pub-id>
</mixed-citation></ref><ref id="bib66"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Meng</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Xiong</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Chu</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2016</year>). <article-title>Enhanced production of avermectin by deletion of type III polyketide synthases biosynthetic cluster <italic toggle="yes">rpp</italic> in <italic toggle="yes">Streptomyces avermitilis</italic></article-title>. <source>Letters in Applied Microbiology</source>, <volume>63</volume>(<issue>5</issue>), <fpage>384</fpage>&#x02013;<lpage>390</lpage>.<pub-id pub-id-type="pmid">27538855</pub-id>
</mixed-citation></ref><ref id="bib67"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Miao</surname> &#x000a0;<given-names>V.</given-names></string-name>, <string-name><surname>Co&#x000eb;ffet-LeGal</surname> &#x000a0;<given-names>M. F.</given-names></string-name>, <string-name><surname>Brian</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Brost</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Penn</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Whiting</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Martin</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Ford</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Parr</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Bouchard</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Silva</surname> &#x000a0;<given-names>C. J.</given-names></string-name>, <string-name><surname>Wrigley</surname> &#x000a0;<given-names>S. K.</given-names></string-name>, <string-name><surname>Baltz</surname> &#x000a0;<given-names>R. H.</given-names></string-name></person-group> (<year>2005</year>). <article-title>Daptomycin biosynthesis in <italic toggle="yes">Streptomyces roseosporus</italic>: Cloning and analysis of the gene cluster and revision of peptide stereochemistry</article-title>. <source>Microbiology (Reading, England)</source>, <volume>151</volume>(<issue>5</issue>), <fpage>1507</fpage>&#x02013;<lpage>1523</lpage>.<pub-id pub-id-type="pmid">15870461</pub-id>
</mixed-citation></ref><ref id="bib68"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Mo</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Deng</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Qu</surname> &#x000a0;<given-names>X.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Efficient editing DNA regions with high sequence identity in actinomycetal genomes by a CRISPR-Cas9 system</article-title>. <source>Synthetic and Systems Biotechnology</source>, <volume>4</volume>(<issue>2</issue>), <fpage>86</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">30891508</pub-id>
</mixed-citation></ref><ref id="bib69"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Moore</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Arnscheidt</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Kr&#x000fc;ger</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Str&#x000f6;mpl</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Mau</surname> &#x000a0;<given-names>M.</given-names></string-name></person-group> (<year>1999</year>). <article-title>Simplified protocols for the preparation of genomic DNA from bacterial cultures</article-title>. <source>Molecular Microbial Ecology Manual</source>, <volume>1</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="bib70"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Myronovskyi</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Rosenkr&#x000e4;nzer</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Nadmid</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Pujic</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Normand</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Luzhetskyy</surname> &#x000a0;<given-names>A.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Generation of a cluster-free <italic toggle="yes">Streptomyces albus</italic> chassis strains for improved heterologous expression of secondary metabolite clusters</article-title>. <source>Metabolic Engineering</source>, <volume>49</volume>, <fpage>316</fpage>&#x02013;<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymben.2018.09.004</pub-id><pub-id pub-id-type="pmid">30196100</pub-id>
</mixed-citation></ref><ref id="bib71"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Najah</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Saulnier</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Pernodet</surname> &#x000a0;<given-names>J. L.</given-names></string-name>, <string-name><surname>Bury-Mon&#x000e9;</surname> &#x000a0;<given-names>S.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Design of a generic CRISPR-Cas9 approach using the same sgRNA to perform gene editing at distinct loci</article-title>. <source>BMC Biotechnology [Electronic Resource]</source>, <volume>19</volume>(<issue>1</issue>), <fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s12896-019-0509-7</pub-id><pub-id pub-id-type="pmid">30894153</pub-id>
</mixed-citation></ref><ref id="bib72"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Pickar-Oliver</surname> &#x000a0;<given-names>A.</given-names></string-name>, <string-name><surname>Gersbach</surname> &#x000a0;<given-names>C. A.</given-names></string-name></person-group> (<year>2019</year>). <article-title>The next generation of CRISPR-Cas technologies and applications</article-title>. <source>Nature Reviews Molecular Cell Biology</source>, <volume>20</volume>(<issue>8</issue>), <fpage>490</fpage>&#x02013;<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1038/s41580-019-0131-5</pub-id><pub-id pub-id-type="pmid">31147612</pub-id>
</mixed-citation></ref><ref id="bib73"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qin</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Munnoch</surname> &#x000a0;<given-names>J. T.</given-names></string-name>, <string-name><surname>Devine</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Holmes</surname> &#x000a0;<given-names>N. A.</given-names></string-name>, <string-name><surname>Seipke</surname> &#x000a0;<given-names>R. F.</given-names></string-name>, <string-name><surname>Wilkinson</surname> &#x000a0;<given-names>K. A.</given-names></string-name>, <string-name><surname>Wilkinson</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Hutchings</surname> &#x000a0;<given-names>M. I.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Formicamycins, antibacterial polyketides produced by <italic toggle="yes">Streptomyces formicae</italic> isolated from African <italic toggle="yes">Tetraponera</italic> plant-ants</article-title>. <source>Chemical Science</source>, <volume>8</volume>(<issue>4</issue>), <fpage>3218</fpage>&#x02013;<lpage>3227</lpage>. <pub-id pub-id-type="doi">10.1039/c6sc04265a</pub-id><pub-id pub-id-type="pmid">28507698</pub-id>
</mixed-citation></ref><ref id="bib74"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Qiu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Guo</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2016</year>). <article-title>An active type I-E CRISPR-Cas system identified in <italic toggle="yes">Streptomyces avermitilis</italic></article-title>. <source>PLoS One</source>, <volume>11</volume>(<issue>2</issue>), <fpage>e0149533</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0149533</pub-id><pub-id pub-id-type="pmid">26901661</pub-id>
</mixed-citation></ref><ref id="bib75"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Siu</surname> &#x000a0;<given-names>K. H.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>W.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Riboregulated toehold-gated gRNA for programmable CRISPR-Cas9 function</article-title>. <source>Nature Chemical Biology</source>, <volume>15</volume>(<issue>3</issue>), <fpage>217</fpage>&#x02013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1038/s41589-018-0186-1</pub-id><pub-id pub-id-type="pmid">30531984</pub-id>
</mixed-citation></ref><ref id="bib76"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Skyrud</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Thankachan</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Cabrera</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Seipke</surname> &#x000a0;<given-names>R. F.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>W.</given-names></string-name></person-group> (<year>2018</year>). <article-title>Biosynthesis of the 15-membered ring depsipeptide Neoantimycin</article-title>. <source>ACS Chemical Biology</source>, <volume>13</volume>(<issue>5</issue>), <fpage>1398</fpage>&#x02013;<lpage>1406</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.8b00298</pub-id><pub-id pub-id-type="pmid">29693372</pub-id>
</mixed-citation></ref><ref id="bib77"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tian</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Gu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Sun</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>W.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Developing an endogenous quorum-sensing based CRISPRi circuit for autonomous and tunable dynamic regulation of multiple targets in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Nucleic Acids Research</source>, <volume>48</volume>(<issue>14</issue>), <fpage>8188</fpage>&#x02013;<lpage>8202</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkaa602</pub-id><pub-id pub-id-type="pmid">32672817</pub-id>
</mixed-citation></ref><ref id="bib78"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tong</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Charusanti</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>S. Y.</given-names></string-name></person-group> (<year>2015</year>). <article-title>CRISPR-Cas9 based engineering of actinomycetal genomes</article-title>. <source>ACS Synthetic Biology</source>, <volume>4</volume>(<issue>9</issue>), <fpage>1020</fpage>&#x02013;<lpage>1029</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.5b00038</pub-id><pub-id pub-id-type="pmid">25806970</pub-id>
</mixed-citation></ref><ref id="bib79"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tong</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Whitford</surname> &#x000a0;<given-names>C. M.</given-names></string-name>, <string-name><surname>Blin</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>J&#x000f8;rgensen</surname> &#x000a0;<given-names>T. S.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>S. Y.</given-names></string-name></person-group> (<year>2020</year>). <article-title>CRISPR&#x02013;Cas9, CRISPRi and CRISPR-BEST-mediated genetic manipulation in streptomycetes</article-title>. <source>Nature Protocols</source>, <volume>15</volume>, <fpage>1</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">31863076</pub-id>
</mixed-citation></ref><ref id="bib80"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Tong</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Whitford</surname> &#x000a0;<given-names>C. M.</given-names></string-name>, <string-name><surname>Robertsen</surname> &#x000a0;<given-names>H. L.</given-names></string-name>, <string-name><surname>Blin</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>J&#x000f8;rgensen</surname> &#x000a0;<given-names>T. S.</given-names></string-name>, <string-name><surname>Klitgaard</surname> &#x000a0;<given-names>A. K.</given-names></string-name>, <string-name><surname>Gren</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>S. Y.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Highly efficient DSB-free base editing for streptomycetes with CRISPR-BEST</article-title>. <source>Proceedings Of the National Academy of Sciences of the United State of America</source>, <volume>116</volume>(<issue>41</issue>), <fpage>20366</fpage>&#x02013;<lpage>20375</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1913493116</pub-id></mixed-citation></ref><ref id="bib81"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Volff</surname> &#x000a0;<given-names>J. N.</given-names></string-name>, <string-name><surname>Altenbuchner</surname> &#x000a0;<given-names>J.</given-names></string-name></person-group> (<year>1998</year>). <article-title>Genetic instability of the <italic toggle="yes">Streptomyces</italic> chromosome</article-title>. <source>Molecular Microbiology</source>, <volume>27</volume>(<issue>2</issue>), <fpage>239</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">9484880</pub-id>
</mixed-citation></ref><ref id="bib82"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>W. J.</given-names></string-name>, <string-name><surname>Lin</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>C. Q.</given-names></string-name>, <string-name><surname>Luo</surname> &#x000a0;<given-names>A. L.</given-names></string-name>, <string-name><surname>Xing</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>L.</given-names></string-name></person-group> (<year>2023a</year>). <article-title>Establishing artificial gene connections through RNA displacement-assembly-controlled CRISPR/Cas9 function</article-title>. <source>Nucleic Acids Research</source>, <volume>51</volume>(<issue>14</issue>), <fpage>7691</fpage>&#x02013;<lpage>7703</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkad558</pub-id><pub-id pub-id-type="pmid">37395400</pub-id>
</mixed-citation></ref><ref id="bib83"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Kong</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Hou</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Ye</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2023b</year>). <article-title>AflQ1-Q2 represses lincomycin biosynthesis via multiple cascades in <italic toggle="yes">Streptomyces lincolnensis</italic></article-title>. <source>Applied Microbiology and Biotechnology</source>, <volume>107</volume>(<issue>9</issue>), <fpage>2933</fpage>&#x02013;<lpage>2945</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-023-12429-z</pub-id><pub-id pub-id-type="pmid">36930277</pub-id>
</mixed-citation></ref><ref id="bib84"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Dang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Huang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>He</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Ma</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Huang</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Ma</surname> &#x000a0;<given-names>X.</given-names></string-name></person-group> (<year>2020a</year>). <article-title>Efficient gene silencing by adenine base editor-mediated start codon mutation</article-title>. <source>Molecular Therapy</source>, <volume>28</volume>(<issue>2</issue>), <fpage>431</fpage>&#x02013;<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymthe.2019.11.022</pub-id><pub-id pub-id-type="pmid">31843453</pub-id>
</mixed-citation></ref><ref id="bib85"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wang</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Fan</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Tan</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Ai</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Lam</surname> &#x000a0;<given-names>S. M.</given-names></string-name>, <string-name><surname>Shui</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Lu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Jin</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Xia</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Dannelly</surname> &#x000a0;<given-names>H. K.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name></person-group> (<year>2020b</year>) <article-title>Harnessing the intracellular triacylglycerols for titer improvement of polyketides in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Nature Biotechnology</source>, <volume>38</volume>(<issue>1</issue>), <fpage>76</fpage>&#x02013;<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0335-4</pub-id></mixed-citation></ref><ref id="bib86"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wei</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Tian</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Pan</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Xie</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Bao</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhou</surname> &#x000a0;<given-names>Z.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Development and application of a T7 RNA polymerase-dependent expression system for antibiotic production improvement in <italic toggle="yes">Streptomyces</italic></article-title>. <source>Biotechnology Letters</source>, <volume>39</volume>(<issue>6</issue>), <fpage>857</fpage>&#x02013;<lpage>864</lpage>. <pub-id pub-id-type="doi">10.1007/s10529-017-2309-2</pub-id><pub-id pub-id-type="pmid">28247198</pub-id>
</mixed-citation></ref><ref id="bib87"><mixed-citation publication-type="other">
<person-group person-group-type="author">
<string-name>
<surname>Whitford</surname> &#x000a0;<given-names>C. M.</given-names></string-name>, <string-name><surname>Gockel</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Faurdal</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Gren</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Sigrist</surname> &#x000a0;<given-names>R.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name></person-group> (<year>2023a</year>). <article-title>CASCADE-Cas3 enables highly efficient genome engineering in <italic toggle="yes">Streptomyces</italic> species</article-title>. <source>BioRxiv</source>, <comment>2023.05.09.539971. </comment><pub-id pub-id-type="doi">10.1101/2023.05.09.539971</pub-id></mixed-citation></ref><ref id="bib88"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Whitford</surname> &#x000a0;<given-names>C. M.</given-names></string-name>, <string-name><surname>Gren</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Palazzotto</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Lee</surname> &#x000a0;<given-names>S. Y.</given-names></string-name>, <string-name><surname>Tong</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Weber</surname> &#x000a0;<given-names>T.</given-names></string-name></person-group> (<year>2023b</year>). <article-title>Systems analysis of highly multiplexed CRISPR-base editing in streptomycetes</article-title>. <source>ACS Synthetic Biology</source>, <volume>12</volume>(<issue>8</issue>), <fpage>2353</fpage>&#x02013;<lpage>2366</lpage>. <pub-id pub-id-type="doi">10.1021/acssynbio.3c00188</pub-id><pub-id pub-id-type="pmid">37402223</pub-id>
</mixed-citation></ref><ref id="bib89"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Wu</surname> &#x000a0;<given-names>Y.-J.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>S.-B.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>Z.-Y.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>S.-X.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Improvement of Nemadectin production by overexpressing the regulatory gene <italic toggle="yes">nemR</italic> and nemadectin biosynthetic gene cluster in <italic toggle="yes">Streptomyces Cyaneogriseus</italic></article-title>. <source>Pharmaceutical Fronts</source>, <volume>2</volume>(<issue>04</issue>), <fpage>e151</fpage>&#x02013;<lpage>e159</lpage>.</mixed-citation></ref><ref id="bib90"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Xu</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Wright</surname> &#x000a0;<given-names>G. D.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Heterologous expression-facilitated natural products' discovery in actinomycetes</article-title>. <source>Journal of Industrial Microbiology &#x00026; Biotechnology</source>, <volume>46</volume>(<issue>3&#x02013;4</issue>), <fpage>415</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1007/s10295-018-2097-2</pub-id><pub-id pub-id-type="pmid">30446891</pub-id>
</mixed-citation></ref><ref id="bib91"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yeo</surname> &#x000a0;<given-names>W. L.</given-names></string-name>, <string-name><surname>Heng</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Tan</surname> &#x000a0;<given-names>L. L.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. W.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. H.</given-names></string-name>, <string-name><surname>Hoon</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>M. M.</given-names></string-name>, <string-name><surname>Wong</surname> &#x000a0;<given-names>F. T.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Characterization of Cas proteins for CRISPR-Cas editing in streptomycetes</article-title>. <source>Biotechnology &#x00026; Bioengineering</source>, <volume>116</volume>(<issue>9</issue>), <fpage>2330</fpage>&#x02013;<lpage>2338</lpage>. <pub-id pub-id-type="doi">10.1002/bit.27021</pub-id><pub-id pub-id-type="pmid">31090220</pub-id>
</mixed-citation></ref><ref id="bib92"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yuan</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Jiang</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>Q.</given-names></string-name>, <string-name><surname>Fang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Xiao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2022</year>). <article-title>Biosynthesis of mushroom-derived type II ganoderic acids by engineered yeast</article-title>. <source>Nature Communications</source>, <volume>13</volume>(<issue>1</issue>), <fpage>7740</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-022-35500-1</pub-id></mixed-citation></ref><ref id="bib93"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Yuan</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Huang</surname> &#x000a0;<given-names>C.</given-names></string-name>, <string-name><surname>Singh</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Xun</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2023</year>). <article-title>Automated, self-resistance gene-guided, and high-throughput genome mining of bioactive natural products from <italic toggle="yes">Streptomyces</italic></article-title>. <source>BioRxiv</source>, <comment>2023.10.26.564101. </comment><pub-id pub-id-type="doi">10.1101/2023.10.26.564101</pub-id></mixed-citation></ref><ref id="bib94"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zeng</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Wen</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>He</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Zhai</surname> &#x000a0;<given-names>G.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Deng</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Sun</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2015</year>). <article-title>Highly efficient editing of the actinorhodin polyketide chain length factor gene in <italic toggle="yes">Streptomyces coelicolor</italic> M145 using CRISPR/Cas9-CodA(sm) combined system</article-title>. <source>Applied Microbiology and Biotechnology</source>, <volume>99</volume>(<issue>24</issue>), <fpage>10575</fpage>&#x02013;<lpage>10585</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-015-6931-4</pub-id><pub-id pub-id-type="pmid">26318449</pub-id>
</mixed-citation></ref><ref id="bib95"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zetsche</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Heidenreich</surname> &#x000a0;<given-names>M.</given-names></string-name>, <string-name><surname>Mohanraju</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Fedorova</surname> &#x000a0;<given-names>I.</given-names></string-name>, <string-name><surname>Kneppers</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>DeGennaro</surname> &#x000a0;<given-names>E. M.</given-names></string-name>, <string-name><surname>Winblad</surname> &#x000a0;<given-names>N.</given-names></string-name>, <string-name><surname>Choudhury</surname> &#x000a0;<given-names>S. R.</given-names></string-name>, <string-name><surname>Abudayyeh</surname> &#x000a0;<given-names>O. O.</given-names></string-name>, <string-name><surname>Gootenberg</surname> &#x000a0;<given-names>J. S.</given-names></string-name>, <string-name><surname>Wu</surname> &#x000a0;<given-names>W. Y.</given-names></string-name>, <string-name><surname>Scott</surname> &#x000a0;<given-names>D. A.</given-names></string-name>, <string-name><surname>Severinov</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>van der Oost</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>F.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array</article-title>. <source>Nature Biotechnology</source>, <volume>35</volume>(<issue>1</issue>), <fpage>31</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.3737</pub-id></mixed-citation></ref><ref id="bib96"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Liang</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Luo</surname> &#x000a0;<given-names>Y.</given-names></string-name></person-group> (<year>2020</year>). <article-title>Efficient multiplex genome editing in <italic toggle="yes">Streptomyces</italic> via engineered CRISPR-Cas12a Systems</article-title>. <source>Frontiers in Bioengineering and Biotechnology</source>, <volume>8</volume>, <fpage>726</fpage>. <pub-id pub-id-type="doi">10.3389/fbioe.2020.00726</pub-id><pub-id pub-id-type="pmid">32695773</pub-id>
</mixed-citation></ref><ref id="bib97"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname> &#x000a0;<given-names>J. J.</given-names></string-name>, <string-name><surname>Yamanaka</surname> &#x000a0;<given-names>K.</given-names></string-name>, <string-name><surname>Tang</surname> &#x000a0;<given-names>X.</given-names></string-name>, <string-name><surname>Moore</surname> &#x000a0;<given-names>B. S.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Direct cloning and heterologous expression of natural product biosynthetic gene clusters by transformation-associated recombination</article-title>. <source>Methods in Enzymology</source>, <volume>621</volume>, <fpage>87</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/bs.mie.2019.02.026</pub-id><pub-id pub-id-type="pmid">31128791</pub-id>
</mixed-citation></ref><ref id="bib98"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zhang</surname> &#x000a0;<given-names>M. M.</given-names></string-name>, <string-name><surname>Wong</surname> &#x000a0;<given-names>F. T.</given-names></string-name>, <string-name><surname>Wang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Luo</surname> &#x000a0;<given-names>S.</given-names></string-name>, <string-name><surname>Lim</surname> &#x000a0;<given-names>Y. H.</given-names></string-name>, <string-name><surname>Heng</surname> &#x000a0;<given-names>E.</given-names></string-name>, <string-name><surname>Yeo</surname> &#x000a0;<given-names>W. L.</given-names></string-name>, <string-name><surname>Cobb</surname> &#x000a0;<given-names>R. E.</given-names></string-name>, <string-name><surname>Enghiad</surname> &#x000a0;<given-names>B.</given-names></string-name>, <string-name><surname>Ang</surname> &#x000a0;<given-names>E. L.</given-names></string-name>, <string-name><surname>Zhao</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2017</year>). <article-title>CRISPR-Cas9 strategy for activation of silent <italic toggle="yes">Streptomyces</italic> biosynthetic gene clusters</article-title>. <source>Nature Chemical Biology</source>, <volume>13</volume>, <fpage>607</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2341</pub-id></mixed-citation></ref><ref id="bib99"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zheng</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Li</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Guan</surname> &#x000a0;<given-names>H.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Tan</surname> &#x000a0;<given-names>H.</given-names></string-name></person-group> (<year>2019</year>). <article-title>Enhancement of neomycin production by engineering the entire biosynthetic gene cluster and feeding key precursors in <italic toggle="yes">Streptomyces fradiae</italic> CGMCC 4.576</article-title>. <source>Applied Microbiology and Biotechnology</source>, <volume>103</volume>(<issue>5</issue>), <fpage>2263</fpage>&#x02013;<lpage>2275</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-018-09597-8</pub-id><pub-id pub-id-type="pmid">30685809</pub-id>
</mixed-citation></ref><ref id="bib100"><mixed-citation publication-type="journal">
<person-group person-group-type="author">
<string-name>
<surname>Zheng</surname> &#x000a0;<given-names>T.</given-names></string-name>, <string-name><surname>Hou</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>P.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>Z.</given-names></string-name>, <string-name><surname>Xu</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Niu</surname> &#x000a0;<given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Liang</surname> &#x000a0;<given-names>D.</given-names></string-name>, <string-name><surname>Yi</surname> &#x000a0;<given-names>F.</given-names></string-name>, <string-name><surname>Peng</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Feng</surname> &#x000a0;<given-names>W.</given-names></string-name>, <string-name><surname>Yang</surname> &#x000a0;<given-names>Y.</given-names></string-name>, <string-name><surname>Chen</surname> &#x000a0;<given-names>J.</given-names></string-name>, <string-name><surname>Zhu</surname> &#x000a0;<given-names>Y. Y.</given-names></string-name>, <string-name><surname>Zhang</surname> &#x000a0;<given-names>L. H.</given-names></string-name>, <string-name><surname>Du</surname> &#x000a0;<given-names>Q.</given-names></string-name></person-group> (<year>2017</year>). <article-title>Profiling single-guide RNA specificity reveals a mismatch sensitive core sequence</article-title>. <source>Scientific Reports</source>, <volume>7</volume>, <fpage>40638</fpage>. <pub-id pub-id-type="doi">10.1038/srep40638</pub-id><pub-id pub-id-type="pmid">28098181</pub-id>
</mixed-citation></ref></ref-list></back></article>